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Abstract 
 This thesis presents the development of three-dimensional (3-D) microfluidic 
devices for cellular studies, with focus on applications for high-throughput cell culture 
and cell-based assay.  Microfluidic devices provide potential inexpensive platforms for 
high-throughput screening with the advantages of precise liquid handling, ability to 
control cell culture microenvironment, and reduced reagents and cells.   
 Because a mixture of drugs or chemical compounds can often treat diseases more 
effectively or act synergistically in certain cellular pathways, a device capable of 
screening the combinatorial effects of multiple compound exposures on cells is highly 
desirable.  To this end, a novel method to monolithically fabricate 3-D microfluidic 
networks was developed, and based on this fabrication technology, the first cell culture 
device with an integrated combinatorial mixer was constructed.  The proof-of-concept 
chip having a three-input combinatorial mixer and eight individually isolated micro 
culture chambers was fabricated on silicon utilizing the surface micromachining of 
Parylene C (poly(chloro-p-xylylene)).  Unlike other 3-D microfluidic fabrications, 
multilayer bonding process was favorably obviated.  By incorporating several 
microfluidic overpass structures to allow one microfluidic channel to cross over other 
microfluidic channels, the combinatorial mixer generated all the combinations of the 
input fluidic streams. Cell culturing on-chip was successful, and the ability to 
simultaneously treat arrays of cells with different combinations of compounds was 
demonstrated. 
 To facilitate cell-based assay, another combinatorial cell array device was 
fabricated on glass with incorporated membrane.  Characterization of the combined 
 
 
 
vi 
compound concentration profile at each chamber with a fluorescence method was 
developed.    We demonstrated functionality of the quantitative cell-based assay by 
screening three different compounds’ ability to reduce cytotoxicity of hydrogen peroxide 
on neuron cells and also assaying combinatorial exposures of three chemotherapeutic 
agents on breast cancer cells.  The 3-D microfluidic fabrication process was extended to 
construct multilayer microfluidic device with integrated membrane.  Applications of 
microfluidic devices for marine microbiology were demonstrated.  Based on the 
capabilities demonstrated in this work, devices with high-density cell array and integrated 
high-input combinatorial mixer can be constructed.  At the same time, the technology has 
general applicability for building complex 3-D microfluidic devices, which can broaden 
the applications for current lab-on-a-chip systems.  
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Chapter 1: Cell Culture and Cell-Based Assays 
 
1.1 Introduction to Cell Culture and Platforms 
 
Cell culture is the technique to maintain and grow cells in vitro outside of their 
original environments.  Cell culture has been used extensively as a model system for 
biology, disease, and therapeutics.  It is applied across the disciplines of genetics, 
immunology, cancer, medicine, vaccine production, tissue engineering, and countless 
other applications.   
The cell culture technique was developed over a century ago by Dr. Ross 
Granville Harrison in 1907 [1].   Harrison was working in experimental embryology and 
devised a method to culture and observe frog embryo nerve fiber growth in vitro.  This 
influential technique was gradually refined, and used in primary explants for the next 50 
years.  Several developments in the 1950s popularized the cell culture technique.  The use 
of trypsin allowed adherent cells to be dissociated from surface so subculturing of cell 
lines can be done conveniently.  The use of cells to grow virus and use the virus for 
vaccine production has driven advancement in cell culture technology.  Development of 
antibiotics made it easier to prevent the cell culture from contamination.  One major 
breakthrough occurred in 1952 with the establishment of the first human cell line, HeLa.  
George Otto Gey used cervical cancer tissues from patient, Henrietta Lacks (hence the 
name HeLa), to create an immortal cell line.  This laid the foundation for research in this 
field as HeLa rapidly became adopted in numerous labs for cancer studies and polio 
vaccine testing and development.  The ability to grow human cells also stimulated 
interest in the use of cells as biological models and the use of human tissue for 
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developing cell lines.  More cell lines were established and researchers were able to 
develop growing media suitable for different cell lines.  Cell culture for researchers 
became a more accessible technique as many of the cell lines, reagents and culture 
vessels were reliably manufactured and became available commercially.  For example, 
the American Type Culture Collection (ATCC) currently has over 4,000 cell lines.    
In general, cells for culturing can be divided into three categories: primary, 
secondary, and continuous cell lines.  Primary cells are directly extracted from tissues, 
isolated by either mechanical methods such as dissection and filtration or chemical 
methods with use of enzymes such as trypsin, collagenase, or DNase.  These cells can 
survive outside of their original environment for some time but do not have the capacity 
to proliferate and will eventually die.  While primary cells can be laborious to obtain and 
maintain, primary cells often represent the best biological model because they closely 
resemble the properties of their parent tissue.  Secondary cells, like primary cells, are 
derived from tissues, but secondary cell lines have the capability to divide a limited 
number of times before senescence, the cell’s loss of ability to divide by genetically 
determined events.  MRC-5 is a type of secondary cell that is derived from tissues of 
human lungs.  It has capability to double approximately 50 times before dying and has 
been used in studies such virus infection [2].  Continuous cell lines are able to grow 
continuously.  Continuous cell lines are usually derived from tumor cells that have an 
unstable chromosome number and have undergone transformation such as loss of 
function of the p53 tumor suppressor gene.  Cells can also be induced to become 
immortalized by transfection with genes such as SV40 large T antigen, which affects 
retinoblastoma (Rb) and p53 tumor suppressor proteins [3].  Another method to establish 
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a continuous cell line is by inducing cells to express telomerase.  This prevents the 
progressive shortening of telomeres which normally leads to cell apoptosis after several 
generations [4].  While continuous cell lines can lose some of the cell properties (such as 
loss of contact inhibition) in vivo, or even gain certain functions (such as continuous 
proliferation), continuous cell lines are generally easier and less expensive to maintain 
than primary and secondary cells and offer an unlimited source of identical of cells.  A 
wide selection of continuous cell lines has been developed and researchers can choose a 
particular type suitable for their specific study.   
Cell lines are generally maintained inside a cell incubator with a defined 
temperature and gas mixture (commonly 37oC and 5% CO2).  Culture vessels are flasks, 
petri dishes or well plates made up of glass or disposable plastics.  Polystyrene is the 
most common plastic in the cell culture lab today.  Polystyrene is hydrophobic and 
therefore requires a surface treatment, such as gas plasma, to provide a suitable substrate 
for cell attachment.  Cultured cells are either grown in suspension or adherent cultures.  
Most of the cells derived from tissue require adherence to a surface, while some cells 
such as lymphocytes or sperm cells can be grown in suspension.  Some anchorage-
dependent cells can readily attach to glass or treated plastics, while others require 
attachment factors such as collagen, fibronectin, laminin and poly-L lysine.  Each cell 
line is grown in a unique media consisting of the necessary growth factors, a regulated 
pH, a specific balanced salt concentration, and nutrients such as glucose, amino acids, 
vitamins and carbohydrates.  Serum is commonly used to supply cell culture with growth 
factors, adhesion factors, lipids and hormones.  Most sera are derived from fetal bovine, 
 
 
 
4 
calf, adult horse and human.  Serum-free media is available but is more expensive and 
requires a different formulation for different cell lines.   
Cells should be handled carefully to avoid contaminants.  When taken outside of 
the incubator, cells should be handled in a laminar flow hood, where a constant flow of 
filtered air prevents contamination.  The laminar flow hood can have two flow 
configurations.  Horizontal flow hoods have filtered air directly blowing at the worker.  
Vertical flow hoods blow filtered air from the top of the hood down to the work surface.  
When working with cell cultures, reagents, containers and any other tools such as pipette 
and pipette tips need to be sterile to prevent contamination.  Other aseptic techniques 
such as cleaning the work surface with biocide before use and preventing cross-
contamination between bottles should be followed closely.  During the culture process 
the media has to be changed to replenish the nutrients for cells.  For adherent cells, this 
can be done by aspirating the existing media and replacing it with new media.  For 
suspension cells, the cells are centrifuged to sediment the cells and the media is replaced.  
Some cells lines continuously grow and can fill the culture vessels to reach confluency so 
subculturing to split cells and transfer cells to new vessel is necessary.  For suspension 
cells, pipetting is used.  For adherent cells, cells are washed to remove medium or serum 
and incubated with a trypsin solution to cleave the bonding between the cells and 
substrate so cells can be collected in suspension.  Depending on cell types, some cells can 
also be suspended by using cell scrapers.  Cells can then be diluted and reseeded.  Cells 
can be stored for years using cryopreservation.  This creates a “back-up” of cells to 
protect against genetic drift, contamination, or an unexpected discontinuity of cell line 
such as senescence or equipment failure.  Cryogenic storing can be achieved by placing 
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cells in a container with media and cryoprotectant, typically dimethyl sulfoxide (DMSO) 
or glycerol.  The containers are stored at cryogenic temperatures (below −130oC) by 
placing them in liquid nitrogen or liquid nitrogen vapor.   
Using cells as a model system has several advantages.  Cells are maintained in a 
controlled environment with defined pH, temperature, osmotic pressure and gas mixture.  
Variations that occur in vivo are avoided, making cell culture suitable for systematic 
studies.  Cells can be exposed to media with specific nutrient, protein and hormone 
concentrations.  The duration of this exposure can be controlled.  As opposed to use of 
animals as models, the use of cells is more humane and efficient.  Unlike using tissue or 
animal model, cell lines are a homogeneous group of cells and offer the ability to study 
cell responses with reduced variations due to inhomogeneity inside a tissue.  Experiments 
using cell culture can be replicated as the same cell lines can be used across different labs.  
Cells can be directly exposed to tested compounds such as drugs.  As a result, lower 
amounts of precious compounds are needed than in vivo where the majority of the 
compounds are lost or delivered to body parts not under investigation.   
On the other hand, using cell culture has some drawbacks.  Great care must be 
taken to avoid contamination by bacteria, yeast or other cell lines and expertise is needed 
to perform cell culture experiments under aseptic conditions.  Also, great attention must 
be paid to assess the biological relevance of cell culture experiments.  While primary 
cells are taken directly from tissues, they have been extracted out of their original 
environment and continuous cell lines have undergone transformation.  Some cell-cell 
interactions that occur between different types of cells may be lost and effects by 
endocrine and nervous systems are absent.  Also, unlike cells in vivo, cellular metabolism 
 
 
 
6 
in cultured cells is dominated by glycolysis and the citric acid cycle only has a minor role.  
Cultured cells may also have genetic and phenotypic instability as some cells may 
differentiate and produce heterogeneity in a population.  Therefore, the overall health and 
fidelity of the cell line needs to be constantly monitored.  Straightforward methods 
include observing the cell morphology and counting to determine growth rate.  
Expression of specialized functions by cells can be checked by running polymerase chain 
reaction (PCR) or immunological assays.  In addition, most of the cells are maintained in 
serum, which is poorly defined and can vary from batch to batch.  Despite these 
limitations, cultured cells still express certain specialized functions that are representative 
of the in vivo model and with proper design of experiment, they can be used effectively.  
 The use of cell culture has numerous applications.  It provides a good model for 
studying basic biology and biochemistry.  In these areas, cells have been used to study 
replication and transcription of DNA, protein synthesis, cell metabolism, RNA 
processing, differentiation, apoptosis, intracellular signal transduction, membrane 
trafficking and many other processes.  Virology proved to be one of the initial 
applications of cell culture because of the stringently controlled growing conditions and 
standardization of cell lines for culture and assay of viruses [1].  Cell culture has been 
used for virus detection in the clinical setting and for basic science research of viral 
infections.  Furthermore, cell cultures have been used to produce antiviral vaccines 
including polio, rabies, and hepatitis.  In addition to vaccine production, cell culture can 
be used to produce other products in large scale.  Cells can be engineered to produce 
monoclonal antibodies, insulin and hormones for medical use.  Research is continually 
underway to grow cells into tissue for tissue grafts or organ replacement.  Embryonic and 
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adult stem cells have been investigated to control the differentiation and development of 
these cells.  Cultured cells can also be used to test the toxicity of compounds such as 
cosmetics.  In addition, they can be used to study how those compounds affect the growth 
and health status of certain cells such as liver cells.  Because cancer cells can be cultured 
or normal cells can be transformed to become cancerous, cell culture has been used 
extensively in cancer research.  Culture cells can be used to screen for potential cancer 
drugs and to study drug mechanisms and interactions.  Cell-based screening is important 
in drug development for the pharmaceutical industry.      
  
1.2 Need for High-Throughput Cell Culture, Cell-Based Assay 
and Combinatorial Screening  
 
 Cell-based assay has been applied to various fields.  It has been integral to drug 
discovery and development.  Various drugs for treating different diseases all require 
extensive screening to be done.  Biochemical/molecular assays and cell-based assays 
have both been used for screening.  Biochemical assays often require specific targets for 
screening, and chemicals are tested for their ability to modify the targets.  This is often 
done by testing for ligand binding.  For example, the compounds are evaluated for their 
ability to stimulate or inhibit certain kinases or receptors, such as G protein-coupled 
receptors (GPCRs).  It is also important to test for the selectivity of the potential 
compound because a compound that acts on an undesirable target can induce harmful 
results.  For example, fluorescence resonance energy transfer (FRET) can be used to test 
for protease activity.  In such method, an acceptor fluorescence molecule is bound to one 
side of a substrate while a donor that can transfer energy to the acceptor molecule is 
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bound to the other side.  Upon protease cleavage of the substrate, the distance between 
the donor and acceptor molecules increases and the fluorescence from the donor becomes 
detectable.  This method can also be used for screening protein-protein interactions.   
Cell-based assay has received increased attention and has several advantages over ligand 
binding assay on specific targets.  Cell-based screening can be miniaturized to reduce 
cost and provide “information rich” data [5].  Advances have produced assays that are 
user-friendly while still providing sophisticated results.  While biochemical assay 
requires a specific target, cell-based assay allows the potential compound to interact with 
several targets.  Living cells are the ultimate targets of all drugs and using them as 
models can be more efficient than focusing on isolated genes or proteins.  Cell-based 
assay can test for multiple targets and reveal the effect of a whole transduction pathway.  
Novel target sites and signal pathways can also be discovered during the assay.  The 
development of different cell lines from specific tissues makes it convenient to screen 
drugs for multiple types of cancer [6].  Cell-based screening can be performed in a high-
throughput manner, which is difficult and costly to achieve with animal models.   
 The number of new chemical entities that can be potential drugs and number of 
possible drug targets have increased, and this requires more screening to be done.  
Development in combinatorial chemistry has generated a huge library of potential drug 
candidates that need to be tested and it has been predicted that combinatorial chemistry 
will generate as many as 1030–1050 small molecules to be screened [7].  Advancements in 
genomic, proteomic and metabolomics have resulted in an increase in new chemical 
entities.  Human antibodies, which have been used as drugs, can be screened and 
optimized from a huge library of antibodies produced from phage, mouse antibodies 
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recombined with human antibody genes, and human antibodies raised in mouse grafted 
with human immune cells.  Drug targets are usually enzymes and receptors and current 
drugs only address a total of about 500 molecular targets [8].  Although most of the 
targeted receptors are in the G protein-coupled receptor family, other drug targets include 
DNA, ion channels, nuclear receptors and hormones.  The number of possible targets that 
drugs can act on is increasing as new genes and their associated functions are discovered.  
DNA sequencing projects have revealed novel genes with characteristics similar to G 
protein-coupled receptors.  There are at least 1,000 of these, and many research programs 
are underway to reveal the functions of these new receptors as well as analyze their 
potential to become drug targets.  In a drug screening, panels of compounds are screened 
using various in vitro and cell-based assays to identify compounds that produce positive 
results, or “hits.”  Those compounds are either subject to more complex characterization 
or are modified to produce more specific compounds for screening.  In the beginning of 
1990s, a large screening program would generate 200,000 data points, which rose to 5–6 
million in mid 1990s, 50 million in 2000, and is still rising [8].  The pharmaceutical 
companies are also driven by the desire to lower cost while increasing efficiency.  A 
potential drug is costly to develop from the hit discovery stage to the clinical trials, and 
many compounds fail at the clinical trial stage.  Therefore, better screening techniques 
are needed to lower late stage failure of drugs. 
 Besides compound screening for drug discovery and development, high-
throughput cell-based assays have applications in other fields.  One obvious field is basic 
cellular biology research.  Some areas requiring screening for different factors include 
identifying inhibitors or promoters of cell adhesion, signaling molecules in inflammatory 
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responses, transcription factors, growth factors and molecules causing cell stress.  An 
emerging field, systems biology, which attempts to characterize the interaction of cellular 
pathways and molecular components and to predict the behavior of biological systems, 
requires an enormous amount of data.  Since this type of research is generally carried out 
in academia, it is important that screening be done in high-throughput manner to save 
labor and time while reducing cost.  Also, many start-up pharmaceutical companies 
would like to run high-throughput screenings, but do not have access to high-end 
equipments that large pharmaceutical companies are able to use.  Most high-throughput 
screening instrumentations are costly and can be difficult for many labs and small 
companies to purchase and maintain.  Therefore, inexpensive platforms for high-
throughput screening are highly desirable.   
 Another aspect of biology that adds to the total number of screening experiments 
to be done is that multiple factors can interact with each other to produce synergetic, 
additive or antagonistic results.  Cells are sustained in complex environments and cell 
fates are dictated by the integration of numerous extracellular signals.  Many cellular 
pathways in various biological phenomena are governed by the combinatorial effects of 
several factors.  The regulation of gene expression is governed by activators, repressors, 
general transcription factors, protein-protein interactions, and protein-DNA interactions 
[9, 10].  For example, stem cell differentiation is controlled by multiple factors including 
activators to Notch-related receptor GLP-1, epidermal growth factors (EGF), fibroblast 
growth factors, transforming growth factor β (TGFβ), Macrophage inhibitory protein 1α, 
and numerous others that are currently being identified and studied [11].   
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 In addition, a mixture of drugs can display synergistic interactions and become 
more effective than single agent at treating diseases.  Cancer cells can also develop 
resistance to certain drugs and using a combination of drugs can circumvent this problem 
[12, 13].  For example, treatment of acute lymphoblastic leukemia (ALL) often consists 
of a panel of drugs including vincristine, prednisone, and anthracycline [14].  Initial 
treatment of adult Hodgkin’s lymphoma often includes adriamycin, bleomycin, 
vinblastine, and dacarbazine.  In treating other diseases such as HIV, combination 
therapy has been standard [15].    As a result, drug screenings often include multiple 
combinations of different compounds.  This raises the demand of high-throughput 
screening as the number of potential compounds and all the possible combinations to be 
tested grows significantly. 
 
1.3 Technology for High Throughput Screening  
 
 Currently there are several types of instruments as well as cell-based assays that 
have been used to run in high-throughput manner.  Some of the assay types and the 
technology to handle high-throughput screening will be reviewed.   
 The cell proliferation assay to test cell’s growth in response to external stimuli has 
been implemented for high-throughput screening.  Proliferation assay can be done by 
counting cells after staining with vital and dead cell dyes.  Throughput can be increased 
by running a MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay.  
In such method, yellow MTT is added to the cells which is then reduced to purple 
formazan in the mitochondria of living cells [1].  The change in color can be measured by 
spectrometer.  Cytotoxicity is another type of assay that can be run in similar procedure.  
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Dead cells with compromised membrane can be stained with trypan blue or red 
fluorescent propidium iodide.  Another category of cell-based assay is quantification of 
cellular messengers.  Calcium, Ca2+, a key cellular messenger, can be detected using Ca2+ 
sensitive dyes such as Fluo-3.  Membrane potential can be measured using potential 
indicator dyes such as bis-(1,2-dibutylbarbituric acid) trimethine oxonol (DiBAC4) and 
such detection is important for screening drug targeting ion channels [5].  Gene 
expression is critical to many biological events and it can be measured in living cells, 
providing invaluable tool to study of cell regulation and control.  Most of the methods 
involve transfecting the cells with the genes of reporting enzymes or green fluorescent 
proteins.  Activation of the target gene results in the production of the reporter products, 
which can be detected by a fluorescent, colorimetric or luminescent method.  For 
example, the luciferase gene can be inserted and the subsequent activation results in 
production of an enzyme that converts luciferin into a luminescent form which is then 
detected [16].   When green fluorescent protein is used as the reporter, real-time 
characterization can be done to yield an information-rich readout of the dynamic of 
cellular responses.  Many other assays such as measurement of pH or cAMP also exist.  
More assay systems that act on new targets or pathways and that increase current 
sensitivity are being developed.  Such developments will continue to assist high-
throughput cell-based assay research. 
 Numerous strategies have been developed to run many experiments in parallel for 
high-throughput screening.  Test volumes have continuously been shrinking, with the 96 
well microplate replacing 1 mL assays, followed by the development of 384 well and 
1,536 well microplate.  The individual well sizes are about 0.2 mL, 50 µL, and 2 µL for 
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the 96, 384 and 1,536 well plates, respectively [17].  The reduction in size reduces 
reagents and allows experiments to be run in a high density manner.  Processes are also 
being automated to handle various tasks such as pipetting, assay reading and sample 
storage.  Robots have been developed to handle those tasks and make the process less 
labor intensive and less expensive.  Other instruments such as data processing and 
detectors are integrated with the robots to complete the whole high-throughput screening 
systems.  Robotic systems for automatically handling the whole cell culturing processes 
have been implemented.  Current high-throughput screening robots can run as many as 
100,000 assays per day, which is more than one assay per second [17].  Companies such 
as Aurora Biosciences and Automation Partnership are making robotic systems and 
partnering with pharmaceutical companies to set up high-throughput screening labs.   
 However, while the current robotic systems can handle numerous experiments 
simultaneously in an impressive manner, those methods are limited by some problems.  
Robotic systems are expensive to purchase and maintain, and many academic and small 
companies do not have the resources to use them.  As the wells are miniaturized, the 
liquid handling ability of the dispenser becomes important as small variation can result in 
a relative large impact.  As the volume becomes smaller, evaporation becomes a 
significant problem.  Surface tension can cause the surface of small wells in well plates to 
become uneven, making it difficult to image.  In addition, while the wells for assay are 
miniaturized, the whole robotic systems are still huge and operate in a factory-like setting.  
Automation Partnership’s system is about 150 feet long by 30 feet high and 200 tons in 
weight [17].  Furthermore, it is unlikely that a well plate with higher density than 1,536 
wells per plate can be produced.  However, it is still desirable to further miniaturize the 
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assay size to save cost and reagents.  For all theses reasons, a technology that can perform 
cell-based screening of multiple combinations of compounds in an inexpensive and high-
throughput manner will significantly impact a wide spectrum of fields including systems 
biology, drug discovery and stem cell research. 
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Chapter 2: Lab-on-a-Chip and Microfluidic Systems 
 
2.1 Introduction  
 
 Microfluidics is the field that deals with technology and phenomena of fluid 
behavior and control in the submillimeter length scale.  The term microfluidic device is 
often used interchangeably with lab-on-a-chip (LOC) and micro-total-analysis-system 
(µTAS).  This area has been growing rapidly as a result of advances in biology and 
microelectromechanical systems (MEMS).  Many believe the development of 
microfluidic devices has the potential to revolutionize modern biology and chemistry 
laboratory processes.  The field of microfluidic is interdisciplinary, combining different 
studies in physics, biology, engineering, chemistry and microtechnology.   
 The development of microfluidic system stems from the field of 
microelectromechanical systems (MEMS), which itself is originated from the 
semiconductor industry.  In the 1970s, researchers started to develop microfabrication 
technology and began using silicon to build MEMS devices.  In 1979, Terry el al. 
developed a gas chromatography device on silicon, marking the invention of the first 
microfluidic device [18].  More miniaturized devices based on silicon were developed in 
the 1980s.  Devices such as miniaturized pumps, valves, mixers and sensors were 
invented [19-21].  The successful invention of these new technologies spurred the 
understanding and exploration of novel microfluidic effects.  In 1990, Manz et al. 
proposed that MEMS technologies could be applied to biological and chemical processes, 
and that a single device could incorporate many aspects of laboratory processes including 
sample preparation, separation, sample transport and detection [22].  Such devices have 
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been termed lab-on-a-chip or micro-total-analysis system and have sparked the 
development of microfluidic devices.  These miniaturized devices possess superior 
analytical performance while reducing the amount of reagents required.  This concept has 
been the motivation of the research in this field even today.  One of the most prominent 
microfluidic devices was the electroosmotic pump, which utilized voltage applied on the 
electrical double layer of a channel to drive a fluid.  Such devices did not rely on 
mechanical moving parts for pumps and valves, instead flow at different sections of the 
chip was controlled by adjusting voltage [23].  Electrophoresis devices, which used 
applied voltage to separate charged particles, were also very popular, and were used to 
separate various biological entities [24].  The majority of research during this time 
involved miniaturization of analytical processes and equipments.  In the mid 1990s, the 
field of microfluidic started to bloom, and the growth can be shown in the dramatic 
increase in number of patents related to microfluidics from 1994 and 2004 [25].  Another 
important development was the use of novel materials other than silicon.  Polymers such 
as PMMA (poly-(methyl methacrylate)), Parylene C ((poly(chloro-p-xylylene)), SU8 and 
PDMS (polydimethylsiloxane) were all used to construct microfluidic devices.  Recently, 
microfluidic devices have been integrated into novel applications such as gene 
sequencing, flow cytometer, fuel cells, and disease diagnostics.    
However, the field of microfluidics has many obstacles to overcome before 
widespread acceptance.  For example, the adoption of microfluidic devices by researchers 
outside of this community has been slow because the devices are often complicated to use.  
External fluid delivery systems have to be carefully coupled with the microfluidic chip to 
provide proper sealing and true reduced reagent volumes.  Unlike larger instrumentation, 
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small bubbles in the microchannel can cause devastating device failures.  Furthermore, 
while the microfluidic device itself is small, the external detectors, sample injection, and 
pumping systems are often bulky.  Finally, researchers have found that simply 
miniaturizing existing instrumentation does not always improve functionality over the 
existing mature technology.  Looking into the future, microfluidic devices need to 
become simpler to use to gain adoption.  In addition, microfluidic devices need to be used 
in high demand applications and provide valuable and novel utilities instead of merely 
miniaturizing existing technologies.    
Despite current challenges for widespread acceptance, microfluidic devices 
provide various advantages over macro devices.  One obvious advantage that was 
recognized very early was the small scale of the devices.  As the length scale is reduced, 
processes such as diffusion and thermal energy transfer are significantly faster and 
devices can operate with faster analysis and response time.  The small size also makes 
microfluidic devices portable for clinical or field use in point-of-care diagnostics.  In 
addition, microfluidic devices are small enough to make them implantable devices such 
as drug-delivery devices or continuous blood-monitoring devices.  Because the device is 
compact, more experiments can be run in parallel or on one single chip to increase 
throughput.  Microfluidic devices have the capability to handle liquid precisely in the 
nanoliter range and reduce cost of running experiments by requiring less reagents.  In 
addition, each device requires minimal material cost for construction, and using 
microfabrication steps, devices can be mass produced.  Mass manufactured low cost 
sensors can be deployed in large quantities for applications such as defense against 
terrorist biological warfare attacks.  Devices can be made disposable, providing user-
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friendly operating process and sterile experimental conditions for each experiment.   
Different components of analytical or biological experimental processes can be integrated 
on a single microfluidic chip to provide a platform with multiple functionalities.    
 
2.2 Fabrication Technologies for Microfluidics 
 
 Many different methods have been developed for fabricating microfluidic devices.  
The first microfluidic devices in the 1980s utilized fabrication technology borrowed from 
MEMS (microelectromechanical systems) and the semiconductor industry.  Most of these 
devices were fabricated with bulk micromachining, which involved etching of substrates 
such as silicon or glass and bonding of the different layers.  Other methods that were 
developed eventually included surface micromachining, the deposition and patterning of 
various thin film layers.  Recent development of soft lithography, the process of micro-
molding soft elastomers, has gained wide reception because of its simplicity.  Other 
processes such as injection molding, hot embossing and laser ablation have all been 
applied to microfluidic fabrication.  The details of the different fabrication techniques 
will be presented in the following sections.   
 One common technique that is used in many microfluidic fabrications is 
photolithography.  Photolithography involves coating (usually by spin-coating) a 
photosensitive photoresist on a substrate and baking of the photoresist to slightly harden 
it.  A mask is made with a pattern that has areas that either block or allow light to pass 
through.  Depending on the type of photoresist, exposed areas become soluble or 
insoluble in developer.  The patterned photoresist remains after developing and can be 
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used as masking material during etching of the underlying substrate or as a structural or 
sacrificial material itself.     
2.2.1 Bulk Micromachining  
 
 Bulk micromachining involves patterning a substrate, usually silicon or glass, by 
selectively etching the substrate and creating structures such as trenches or holes inside 
the substrate.  This is a popular technique because various etchants have been extensively 
studied and developed.  Furthermore, the etching profile (isotropic or anisotropic), 
selectivity and rate can be precisely controlled. 
 To wet etch silicon isotropically, or etching with the same rate in all direction, 
HNA (HF, HNO3, and CH3COOH) can be used [26].  The HNO3 is used to oxidize the 
surface while HF can dissolve the oxidized product.  CH3COOH is used for the transport 
of products and reactants.   
 To create more complex shapes, chemicals for anisotropic etching can be used.  
The anisotropic property arises because the etchant etches one crystal orientation faster 
than the other.  The etchant usually contains alkaline solution to dissolve silicon.  Typical 
etchants include KOH, EDP (ethylene-diamine pyrocatechol), and TMAH ((CH3)4NOH).  
These etchants have a 10 to 400 times higher etching rate in the <1 0 0> plane than the  
<1 1 1> plane.  EDP was the first etchant developed but suffers from high toxicity and 
less selectivity than the other two.  KOH has the best selectivity among the three and is a 
good chemical to use for creating grooves.  However, KOH also etches away material 
such as SiO2 and aluminum.  TMAH has lower selectivity than KOH but is compatible 
with CMOS fabrication processes.  Glass, which is often a preferable substrate to silicon 
for biological imaging applications, can be etched using HF solutions.  However, the 
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etching rate can be slow and masking material such as photoresist is etched too.  
Therefore, in many applications silicon is preferred to glass. 
 The dry etching process using plasma can be applied for bulk micromachining of 
silicon.  Although wet etching is typically less expensive, easier to implement, and etches 
at a higher rate, plasma etching has certain advantages.  Plasma etching produces smaller 
feature sizes than wet etching because the wet process can indiscriminately damage the 
other features on the substrate.  Furthermore, dry etching does not cause undesirable 
results such as delamination of the bonded layers.  Plasma etchers typically use a gas with 
fluorine such as SF6 or CF4.  These gases are charged to become high energy plasma that 
produces fluorine free radicals.  The fluorine free radicals react with the silicon to etch it.  
SF6 is the most common gas used in dry etching and the reaction results in gaseous 
products of SiF6.  Depending on the plasma etcher configuration, etching profiles from 
isotropic to slightly anisotropic to totally vertical can be produced.  Typical plasma 
etchers, which have a RF power electrode at the top of the chamber, away from the 
substrate, produce an isotropic etching profile.  Reactive ion etching (RIE), utilizes a 
power electrode at the bottom in contact with the substrate.  This causes the plasma 
particles to accelerate preferentially towards the substrate, producing a more anisotropic 
profile.  Deep reactive ion etching (DRIE) produces the most vertical sidewalls by using 
a switching chemistry between SF6 and C4F8.  The C4F8 passivates the sidewalls of a 
trench, forming a protective layer from the subsequent SF6 etching, which makes the 
trench deeper.  The two gases are continuously switched and aspect ratio of 30:1 can be 
achieved.   
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 The etched patterns are generally bonded with another substrate such as glass or 
silicon to complete the microchannels.  Three common bonding methods have been 
developed and used extensively: Si-Si fusion bonding, anodic bonding and eutectic 
bonding.  In fusion bonding, the Si surface is cleaned and hydrated to produce OH 
functional groups on the surface.  The two surfaces are brought in contact at one point to 
start a “contact wave” that propagates through the whole surface.  Then, the two surfaces 
in contact are thermally annealed at 800oC to 1200oC to create covalent Si-O-Si bond 
with the removal of H2O group.  The bond strength can be comparable to that of intrinsic 
silicon.  Anodic bonding is used to join a silicon substrate with a Na+ based material such 
as Pyrex glass.   The two surfaces are cleaned and brought into close contact.  The two 
surfaces are heated to temperature of 200oC–500oC, and a voltage of 200 V–1,000 V is 
applied with the more positive potential on the silicon.  The applied voltage causes the 
positive Na+ to be displaced from the bonding surface, leaving negative charges at the 
interface.  The resulting electrostatic force and migrations of ions facilitate formation of 
chemical bonds which would otherwise require temperature of around 1,000oC.  This is a 
versatile technique as Pyrex can be sputtered as a thin film and used as a glue to bond Si 
to other surfaces.  In eutectic bonding, eutectic alloys such as Au/Sn are coated on the 
substrate and used as glue.  The surface coated with the eutectic layer is brought together 
with another surface and heated to the eutectic point inside a vacuum chamber to 
facilitate bonding. 
2.2.2 Surface Micromachining 
 
 Surface micromachining involves deposition and selective patterning of layers of 
sacrificial and structural thin films on the substrate.  Unlike bulk micromachining, the 
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substrate remains intact.  The layers are patterned with photolithography.  Sacrificial 
layers aid in defining the final shape of the device and are removed using specific solvent.  
Structural layers remain and form the final device.  The process flow for the general 
surface micromachining process is shown in Figure 2-1.   
 
Figure 2-1. General process for fabrication of microchannel with surface micromachining.  
Access holes can be made from the top or bottom side of the substrate.  
 
 In surface micromachining, polysilicon is most commonly used as the structural 
material and silicon dioxide as the sacrificial material.  Both polysilicon and silicon 
dioxide can be deposited using the chemical vapor deposition (CVD) process.  
Polysilicon can be etched using SF6 plasma etching and silicon dioxide can be removed 
using HF solution.   
Surface micromachining is not limited to glass and silicon substrates.  A wide 
variety of materials can be used as long as the process used for the removal of sacrificial 
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layer does not damage the structural layer.  When using alternate materials for surface 
micromachined devices, it is important to ensure that the adhesion between the different 
deposited layers is strong.  It is especially important to choose the proper solvent and 
dissolution procedure to remove the sacrificial layer as improper choice can result in 
delamination of the deposited layers.  Many combinations of materials have been used for 
surface micromachining and recently the use of polymers has drawn much attention.  
With polymers, photoresist can be used as the sacrificial layer and removed by 
dissolution in organic solvent such as acetone.  Polymers such as PMMA, Parylene and 
SU8 can be deposited on the photoresist to form microfluidic channels.  Access holes for 
making fluidic connection to the fluid delivery macro components can be made either at 
the bottom or the top of the device.  Making access holes from bottom requires bulk 
micromachining to create holes through the entire substrate which is time consuming and 
expensive.  Also, care must be taken to ensure that etching through the whole wafer does 
not affect the features on the top side.  When access holes are made on the top of the 
device, channels need to be protected from the coupling pieces such as o-rings and 
gaskets to prevent channels from collapsing.  In this case, a conformal coating of thick 
polymers such as SU8 can be applied and patterned as a protective layer.   
2.2.3 Soft Lithography 
 
 Soft lithography refers to the micro-molding of soft elastomers, most commonly 
PDMS (polydimethylsiloxane).  PDMS has the advantage that it is flexible, optically 
transparent and inexpensive.  Soft lithography has gained popularity since 1995 because 
it does not require complex equipments and has a short fabrication time.  Many labs that 
do not have in-house cleanroom facilities can have access to microfluidic devices using 
 
 
 
24 
soft lithography.  The general PDMS fabrication procedure starts with the fabrication of 
the mold.  This can be done by patterning silicon wafers using DRIE or other bulk 
micromachining processes or patterning SU8, a negative photoresist that can achieve 
thicknesses of 100 µm or more.  PDMS prepolymer generally consists of two 
components of polymer base and curing agent.  A typical PDMS, Sylgard 184, generally 
consists of polymer base and curing agent mixed at a ratio of 10:1.  Next, the mixture is 
casted on the mold and cured by heat.  Sylgard 184 can be cured in 80oC oven in 30 
minutes.  After curing, the PDMS piece is removed from the mold.  Access holes are 
punched through the PDMS with a blunt-end syringe needle.  The PDMS piece is then 
bonded to another substrate such as glass or another piece of PDMS.  To bond PDMS to 
glass, the two pieces can be treated with oxygen plasma and bonded together via 
hydrophilic interaction [27].  PDMS can also be bonded to another piece of PDMS to 
create monolithic structures [28].  This can be achieved by treating both PDMS surfaces 
with oxygen plasma and bonding them together.  Another method is by partial curing: 
both pieces of PDMS are cured for a short period of time at lower temperatures (~60oC) 
and become hardened enough to handle but not totally cured.  The two pieces are then 
brought into contact and cured together.  This method has been useful in constructing 
PDMS valves and pumps where two layers of PDMS channels sandwich a thin PDMS 
layer in between them.  The top control channel is actuated pneumatically to push the thin 
PDMS piece down to seal the bottom fluidic channel.   
 While PDMS has been a popular material for microfluidics, it has several 
shortcomings.  Complex structures can be difficult to achieve and the aspect ratio is 
limited from 0.2 to 2 [29].  Features with small dimensions can be hard to replicate 
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faithfully.  PDMS devices are unable to withstand high pressure and the typical methods 
used to bond glass to PDMS have working pressures limited to a maximum of 80 psi [27].  
PDMS is highly porous, and diffusion of water vapor can lead to undesirable drying of 
the sample or even osmolarity change [30].  Small molecules can diffuse into or out of 
the bulk of PDMS, and this can produce undesirable effects such as decreasing the 
concentration of the input compounds for exposure on cells or target molecules for 
detection [31].  Because PDMS is permeable to most organic solvents, it swells 
significantly after exposure to organic compounds.  Although pretreatment of the PDMS 
surface is generally used to reduce permeability, it is often inadequate.  This is a serious 
drawback and makes it impossible to use PDMS in many applications.  Because of these 
limitations, polymers with similar properties to PDMS but more chemically resistant are 
currently being developed.   
2.2.4 Other Fabrication Processes 
 
 Conventional processes for making polymer parts have been applied to make 
microfluidic devices.  Processes such as hot embossing and injection molding have been 
applied [32].  In the hot embossing process, the mold and polymer are heated to the 
polymer’s glass transition temperature inside vacuum, and the mold and polymer are then 
brought in contact with an applied force.  This results in the pattern on the mold being 
stamped into the softened polymer.  In injection molding, polymers in granular pellets are 
forced into a cylinder and start to melt.  The molten polymer is injected into a cavity 
containing a mold at 60 to 100 MPa.  While these processes are unable to achieve highly 
complex structures that photolithography technology is capable of, these technologies are 
more matured and require shorter fabrication time and lower cost.  Another advantage is 
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the wide range of polymer materials that are available including polymethylmethacrylate 
(PMMA), polypropylene (PP), polystyrene (PS) and polycarbonate (PC).  As a result, 
those processes are more commonly used in making commercial microfluidic products.  
Another method is to use laser ablation to directly create microfluidic channels on 
plastics or glass.  In laser ablation, a laser is shined on the material, breaking chemical 
bonds inside the material.  Laser ablation has been applied to materials including glass, 
ceramics, polymers and metals.   
 After the pattern for the microchannel is made, bonding has to be done to enclose 
the channels.  Process such as lamination, gluing, and thermal bonding can be applied to 
bond polymer-based microfluidic devices.  In the lamination method, a film coated with 
an adhesive layer is sandwiched in between the polymer chip and another substrate such 
as glass.   The setup is rolled into two heated rollers and the adhesive film is melted, 
joining the two pieces together.  Gluing can also be used to join two pieces together.  For 
both the gluing and lamination processes, care should be taken to avoid blocking the 
channel with the adhesive layer.  Another way to join polymer pieces is by heating the 
polymers and applying pressure to seal the device.  
 
2.3 Parylene Microfluidics 
 
 Parylene has emerged as a popular choice of material for constructing 
microfluidic devices.  Many of the fabrication processes presented in the following 
chapters are based on Parylene.  Also, the type of Parylene mentioned in the rest of the 
thesis refers to Parylene C, unless otherwise specified.  The background, properties, 
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deposition, and pattering of Parylene for microfluidic device fabrication will be discussed 
in this section.  
2.3.1 Parylene Background and Properties 
 
 Parylene has several unique material properties that make it advantageous to use 
as a microfluidic material.  Parylene is transparent, chemically inert, and biocompatible.  
Parylene is conformally coated onto a surface using chemical vapor deposition method 
and deposition thickness can range from 0.1 to 1,000 µm.  Parylene deposition is 
performed at room temperature and is suitable for encapsulating delicate items such as 
electronics and medical devices.  Researchers eventually discovered Parylene’s 
compatibility with CMOS/MEMS fabrication process and its superior material property 
has made it the material of choice for constructing microfluidic devices. 
 Parylene was first discovered in 1947 by Professor Michael Szwarc at University 
of Manchester in the United Kingdom when he was studying the chemical bonds in 
molecules such as xylenes, which have a carbon attached to a benzene ring [33].  Because 
he was interested in studying the bond strength, he heated the chemicals to a high 
temperature.  He eventually noted formation of a thin film in downstream cooler area 
zone, and was intrigued by the unique physical and chemical property of the film.  The 
material was named “Szwarcite,” which is today’s equivalent of poly-p-xylylene or 
Parylene N.  The discovery spurred commercial interests and William Franklin Gorman 
proposed a chemical vapor deposition method to create Parylene film with the dimer of 
the p-xylylene as starting material.  The “Gorman” process is still used in many Parylene 
coaters today.  However, the synthesis of stable dimer was not reliable until Donald Cram 
at UCLA developed a method to synthesize the dimers in 1951.  This development made 
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the commercialization of the Parylene deposition process viable.    Over 20 types of 
Parylene were subsequently commercialized, while three types, Parylene N, Parylene C 
and Parylene D have been most commonly used (Figure 2-2).  The recent development of 
Parylene HT has introduced another Parylene with superior material properties such as 
increased thermal stability, improved electrical properties, increased ultraviolet stability, 
and a lower coefficient of friction.   
 
Figure 2-2. Chemical structures of the common Parylenes. 
 
 Parylene N, poly-p-xylylene, is the most basic form in the Parylene family.  It is 
completely linear with no functional groups substituted.  Parylene N has high dielectric 
strength and has constant dielectric across a large frequency range (2.65 from 60 Hz to 1 
MHz) [34].  Parylene C has one aromatic hydrogen substituted with a chlorine group. 
Parylene D has two substituted chlorine groups and is able to maintain its mechanical and 
electrical properties at higher temperature.  Parylene C is the most common Parylene for 
microfluidics.  Parylene C has the highest mechanical strength among the three common 
Parylenes with Young’s modulus of 400,000 psi.  Because Parylene is deposited in a 
conformal and pinhole-free manner, it exhibits low permeability to moisture and gases 
and is stable toward many organic solvents [34].  Parylene C has been shown to be 
biocompatible and is certified with the stringent biocompatibility rating of both United 
States Pharmacopeia (USP) Class VI by the Food and Drug Administration (FDA) and 
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ISO 10993.  It is resistant to corrosive body fluids and has been used to coat many 
chronic implantable devices [35, 36].  Parylene C is also preferred over the other two 
types of common Parylenes because it has the highest deposition rate of 2–3 µm/hr.  In 
addition, Parylene C is transparent in the visible range which allows microfluidic devices 
for biological applications to be readily coupled with microscopy techniques.     
2.3.2 Parylene Microfluidic Fabrication Process 
 
 Fabrication of Parylene-based microfluidic networks is based on surface 
micromachining techniques.  The Parylene deposition and etching process will be 
described in this section. 
 Figure 2-3 shows the generalized Parylene deposition process using chemical 
vapor deposition (CVD).  The simplified model of the Parylene deposition consists of 
three distinct stages: vaporization, pyrolysis and deposition [34].  The pressure difference 
in each of the three zones (1, 0.5 and 0.1 torr) drives the flow of the vapor.  First, the 
Parylene dimers are loaded into a boat and are vaporized by heating to 150oC.  At this 
temperature, the dimers are sublimed and the vapor enters the pyrolysis zone.  The 
pyrolysis zone is approximately 680oC, and at such temperature, the cleavage of the 
methylene-methylene bond occurs.  This yields the Parylene monomer, para-xylylene, a 
diradical monomer.  Finally, the monomers enter the deposition chamber, where they 
adsorb and polymerize on the substrate at room temperature.  When the monomers enter 
the deposition chamber, some adsorb to the substrate.  Some of these monomers will 
desorp and leave the surface, while others come in contact with each other and begin the 
nucleation process [37].  The polymer propagates until all the monomers are used or until 
the process is stopped.  It has been shown that the deposition rate can be increased by 
 
 
 
30 
decreasing the substrate temperature and it was suggested that the higher deposition rate 
is a result of the increased condensation of the monomers on the surface. 
 
Figure 2-3. The Parylene deposition process.  (a)–(c) show the chemical structures of 
Parylene at corresponding time points.  Image adopted from [38]. 
 
 One key advantage of this deposition process is the formation of a pinhole-free 
conformal coating on the substrate.  Unconformal coatings lead to an inhomogeneous 
surface, and because of the large surface area to volume ratio in miniaturized devices, 
small inhomogeneities can be detrimental to the device.  Another advantage of using 
CVD process is that the monomer gas is converted to polymer film directly, without 
catalysts or solvents.  In addition, this coating process is substrate independent and 
almost all materials can be coated.  The deposition occurs at room temperature and is 
compatible with existing MEMS/CMOS fabrication process and materials.   
 After Parylene is deposited, it can be selectively etched with many processes.  
Parylene can be removed using a solvent such as chloronaphthalene or benzolyl benzoate 
at 150oC [39].  However, such process is not compatible with lithographic procedures.  
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UV laser ablation is also possible but is hampered by low throughput and high cost.  
Using plasma etching is the most practical and common method to pattern Parylene.  
Oxygen plasma can be used to etch Parylene with photoresist.  As photoresist can be 
etched by oxygen plasma, a photoresist slightly thicker than the Parylene thickness has to 
be used.  Metals such as gold or aluminum can also be used as the masking material.  
Plasma etching, reactive ion etching (RIE) and deep reaction ion etching (DRIE) can all 
be used to pattern Parylene [39].  RIE can achieve more vertical sidewall profile than 
plasma etching, while DRIE can achieve the most vertical sidewall profile.  Typical 
etching rate is about 0.1 to 0.5 µm min−1. 
 The deposited Parylene can be etched and followed up by other lithographic 
processes.  Photoresist can be patterned on Parylene with good adhesion.  Metals such as 
Cr/Au, Ti/Pt and Al can be deposited on Parylene using thermal or e-beam evaporation.  
Those metal layers can be patterned by the typical lithographic and etching processes as 
Parylene is inert to most solvents.  Functionalized Parylene molecules with substituted 
groups such as aminomethyl or carboxylic acid have been synthesized and can be used to 
couple molecules such as proteins [40]. 
 A typical process to construct Parylene microchannel utilizes the surface 
micromachining technique.  Photoresist is first patterned on the substrate and Parylene is 
deposited.  Parylene is patterned to make the access holes on the top side and the 
sacrificial photoresist can be eluted using acetone.  Alternatively, access holes can be 
patterned from the bottom side by performing bulk micromachining.   
 To date, various integrated microfluidic devices and individual components have 
been made by extending the basic surface micromachining procedure.  Some examples 
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include peristaltic pumps, electrolysis pumps, check valves, modular microfluidic 
systems and cytometers [41-44].  Parylene has also been applied to devices outside of 
microfluidic such as bioMEMS and implantable devices with examples including retinal 
implants and eye pressure sensing micro devices [45, 46].   
 
2.4 Microfluidics for Cell Biology 
 In recent years, the applications of microfluidic devices in cell biology have 
grown, and many believe the development in microfluidics will greatly expedite 
advancements in cell biology.  Microfluidics will enable cell biology experimentation to 
be done effectively in a high-throughput manner, with both multicellular and single-
cellular studies.  Reagents requirements for microfluidics devices are a couple of orders 
of magnitude smaller than macro scale devices.  Many microfluidic devices also offer 
functionalities that are unachievable by traditional cell biology instrumentations or 
methods.  Such functionalities are based on the devices’ ability to control the 
microenvironment precisely in both spatial and temporal aspects.  These capabilities have 
allowed microfluidics devices to make biomimetic physiological conditions possible for 
experimentation.  In this section, various microfluidic devices applicable to cell biology 
will be introduced. 
2.4.1 Controlling Microenvironment Using Microfluidic Flow 
 
 One major challenge in studying the cells is to understand the 
microenvironmental factors that regulate cells.  The in vivo microenvironment is 
composed of complex interactions of neighboring cells, extracellular matrix molecules, 
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soluble factors, gas concentrations, physical effects by fluid flows, and temperature 
effects.  Microfluidic flow has provided the ability to precisely control many 
microenvironmental cues for cellular studies.   
 The field of microfluidics has excelled in creating chemical gradients on a single 
chip.  These devices are important because chemical gradients occur readily in vivo and 
their consequences have intrigued scientists for years.  However, a reliable gradient 
generation is hard to achieve in traditional devices.  Jeon et al. utilized the laminar flow 
and diffusion dominant properties of microfluidics to create a well-defined and precise 
chemical gradient on-chip [47]. The device has three inputs and a series of downstream 
dividers and serpentine mixers to continuously split the input streams and join and mix 
them into streams with different and defined concentrations.  For example, by putting 0%, 
50% and 100% of a solution into the inputs, a linear gradient was achieved at the output.  
More complex nonlinear gradient profiles were also achieved.  Such devices have been 
adopted in studying wide array of phenomena caused by chemical gradient including 
chemotaxis of neutrophil and cancer cells and stem cell differentiation [48-50].  
 Microfluidic flow has also been used to expose a single cell to asymmetric signals 
by placing it at the interface of fluid streams.  Because flow is laminar and two streams 
flowing alongside each other undergo minimal mixing, part of the cell receives the 
soluble factors directly while the other part does not.  This has been used in studying 
mitochondrial movement within a single cell [51].  A similar mechanism has been 
applied to expose Drosophila embryo cells to temperature variation by placing a single 
cell at the interface of a warm and a cold stream [52].  Patterning of cells and proteins has 
been enabled by the use of microfluidic devices, and those studies are significant for 
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tissue engineering [53, 54].  Furthermore, the ability to control micro flow precisely has 
enabled the study of shear stress on cells in a convenient and systematic manner [55].  
The microenvironment that cells reside in is composed of cell-cell interaction among 
different groups.  Lee et al. developed a microfluidic device to precisely bring two cells 
in contact with each other for cell-cell interaction studies.  Such devices can be implanted 
for performing studies in high-throughput manner [56].  All these instruments exploit 
unique properties of microfluidics to build devices and enable studies that are not 
possible with traditional macro devices.    
2.4.2 Cellular Analysis Using Microfluidic Devices 
 
  Various processes in cellular analysis were miniaturized with the ultimate goal of 
building a complete system with multiple functionalities integrated on a single chip. 
Separation and sorting of cells is one of the routine process in cellular analysis and 
different cell sorting mechanisms on microfluidic platform have been developed.  Some 
devices are miniaturizations of macro devices while others exploit unique features of 
microfluidics.  One of the most successful methods is to use dielectrophoresis (DEP), in 
which particles (charged or neutral) are subjected to a non-uniform ac field.  Cells are 
separated because the force on them differs depending on the cells’ electrical properties, 
shapes, and sizes.  Mammalian cells were sorted using this method [57].  Another method 
is to use “deterministic lateral displacement” in which an array of post is fabricated and 
particles are flowed through the posts.  Small particles can follow the streamlines and 
stay in one lane, while large particles will continue to be displaced to another lane.  This 
method has been applied for sorting cells such as blood cells in whole blood [58].  Cell 
cytometers, both using optical and impedance-based detection schemes have been created 
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as well [42, 59].  Cell lysis functionality has been made possible by either using barbs to 
mechanically lyse the cells or applying electric field to electrically lyse the cells [60, 61].  
In addition, chips that are capable of analyzing cell lysates have been made.  Systems 
such as on-chip PCR were fabricated and because of low thermal-mass of microsystems, 
fast cycling was possible [62].  Other components such as HPLC, capillary 
electrophoresis or isoelectric focusing have all been made [43, 63, 64].  Besides 
analyzing cell aggregates, single cells can also be analyzed in a high-throughput manner 
by taking advantage of the ability of microfluidic devices to position cells precisely.  
Carlo et al. created a device to efficiently position single cells in individual traps [65]. 
While these works focus on demonstrating the capability and advantages of using 
microfluidic systems, efforts must be put into improving compatibility with existing 
laboratory processes and integrating the various components for microfluidic devices to 
gain wider adoption.  
2.4.3 Microfluidic Cell Culture and Cell-Based Assay Systems 
 As discussed in the previous chapter, cell culture and cell-based assay is a key 
process in various fields including pharmacology, cell biology and tissue engineering.  
High-throughput experimentation is desirable, but a reliable and cost-effective platform 
has been hard to achieve.  Recently, many researchers have been developing microfluidic 
devices as potential inexpensive tools for high-throughput cell-based assays.  The 
advancements in microfabrication and microfluidic technologies have enabled the 
development of various lab-on-a-chip devices with cell culturing functionalities.  Using 
microfabrication techniques, chip-based devices with high-density arrays can be mass 
fabricated.  Performing cell culture and assays with microfluidic devices also possesses 
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the advantages of increased throughput, precise liquid handling in the nanoliter range, 
and reduced sample volume.  Fewer cells can be used for each experiment and this is 
beneficial for performing experiments on rare cells such as stem cells or primary cells.  
Furthermore, on-chip culture systems offer culture environments with characteristic 
lengths at the micro scale and the cell culture environment on-chip can be designed to 
better mimic the in vivo culture microenvironment than traditional cell culture systems.
 Various on-chip culture systems with different functionalities have been 
developed.  Prokop et al. developed a device to culture cells inside microfluidic channels 
and was able to culture cells for 5 days [66].  Hung et al. created a device with separate 
cell loading and media perfusion inlets to efficiently collect cells and perfuse them 
without cell loss [67].  The setup also enabled cell passaging by using trypsin, and cell 
culture over 2 weeks was achieved.   To date, an abundant number of cell types have 
been successfully cultured on-chip, including human hepatocytes, fibroblasts, osteoblasts, 
stem cells, breast cancer cells and many others [68].  Devices that integrate other 
microfluidic capabilities have been created.  Cell culture arrays were integrated with 
concentration gradient generators to expose them to a single compound at different 
concentrations [50, 69].  King et al. developed a chip with a high-density cell array and 
monitored gene expression in real time using reporter genes with green fluorescent 
proteins [70].  In a single experiment, multiple stimuli were applied to treat the cells at 
once and ~5,000 measurements were made.  A creative device was made by Kim et al. 
that cultured cells under a logarithmic range of flow rates simultaneously and studied the 
cell responses at different flow rates [71].  Cell patterning and long-term studies of 
cellular differentiation using perfusion systems on-chip were demonstrated [72].  
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However, most of the current devices are not designed to screen for multiple compounds 
at once.  Chip-based devices that have the capability to handle two or more inputs and 
assess the effects of multiple compound exposures on cells are valuable for numerous 
screening applications.   
 
2.5 Microfluidic Phenomena Related to Cellular Studies 
 
 As the scale of the culture environment is reduced to micron scale, some of the 
dominant forces and physical phenomena in macro scale can become less important.  On 
the other hand, other forces and physical phenomena that are generally ignored in macro 
device design can start to dominate.  This provides the opportunity to exploit novel 
properties of microfluidics to achieve various functionalities unattainable by macro 
devices.  Also, it is important to consider the dominant phenomena in microfluidic 
devices when designing devices for cellular studies.  This section will briefly review 
some of the physics at micro scale pertinent to microfluidic for cellular studies.   
2.5.1 Laminar Flow 
 
 In macro scale fluidic devices, flow is often turbulent, which is chaotic and 
unpredictable.  However, in microfluidic devices, flow is generally laminar, in which the 
position of particle inside a fluid stream as a function of time can be predicted.  In 
laminar flow, fluid can be treated as composition of several thin layers, or laminae, and 
the layers flow parallel to each other without disruption.  One dimensionless number that 
gives an indication of the flow regime is the Reynolds number, Re, and is defined [73] 

 hvDRe ,                                                         (2.1) 
 
 
 
38 
where ρ is the density of the fluid, v is the velocity of the fluid, µ is the fluid viscosity and 
Dh is the hydraulic diameter, which is dependent on the channel’s cross section geometry.  
Re < 2300 indicates the flow is in the laminar regime, and given the small size of 
microfluidic channels, most of the microfluidic flows have Reynolds number less than 1.  
As a result of this, two fluid streams flowing alongside each other inside a microchannel 
will mix only by diffusion.    
 Pressure driven incompressible flow is described by two equations, the Navier-
Stokes equation [74]: 
vpvv
t
v  2

 
  ,                                      (2.2) 
 
and the equation for conservation of mss: 
0 v ,                                                            (2.3) 
 
where v  is the fluid velocity, p is the pressure, µ is the fluid viscosity, t is the time and ρ 
is the fluid density.   
 For microfluidic design consideration, the analytical solution for the Navier-
Stokes equation can be solved assuming the no-slip boundary conditions.  The exact 
solution depends on the cross sectional geometry of the microfluidic channel, but the 
flows always follow a parabolic profile.  The steady state velocity profile for a 
rectangular channel can be approximated by the parallel plate Poiseuille flow [75]: 
 yyh
L
Pyvx  2)( .                                                  (2.4) 
 
The velocity in the x direction, vx, is a function of the position along the channel height, y, 
and h is the channel height, ∆P is the pressure difference of the two ends of the channel, 
L is the length of the channel, and µ is the viscosity of the fluid.   
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Flow profile can also be described conveniently using a fluidic resistance concept.   
QRP  .                                                              (2.5) 
The pressure drop, ∆P, is equal to the product of volumetric flow rate through a channel, 
Q, and fluidic resistance of the channel, R.  For a rectangular channel, the fluidic 
resistance is [73] 
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where w is the width of the channel, h is the height of the channel and L is the length of 
the channel.  For channel with width much larger than height, the resistance can be 
approximated as  
3
12
wh
LR  .                                                           (2.7) 
 
2.5.2 Diffusion  
 
 Diffusion can be the dominant transport process in microfluidic channels.  
Diffusion is the process by which particles move from higher concentration regions to 
lower concentration regions because of Brownian motion.  In one dimension, diffusion 
can be modeled by the equation: 
Dtd 22  ,                                                        (2.8) 
 
where d is the mean distance that a particle travels, D is the diffusion constant and t is the 
time.  Diffusion becomes important when the time is long or the distance is short, so it is 
inconsequential in channel with centimeter or wider widths.  Typical diffusion constant 
for some molecules in water are 2 × 103 µm2 s−1 for solute ions, 100 µm2 s−1 for small 
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proteins and 0.02 µm2 s−1 for mammalian cells.  A dimensionless number that indicates 
whether convection or diffusion is dominating is the Peclet number, Pe, 
D
vlPe  ,                                                             (2.9) 
where v is the fluid velocity, l is the characteristic length and D is the diffusion constant.   
When the velocity is high, convective transport dominates, while when the length is small, 
diffusion dominates. 
2.5.3 Shear Stress 
 
 Shear stress is the tangential force applied to the surface of an object.  Inside a 
microfluidic channel, the shear stress at the wall is given by the equation, 
dy
dv  ,                                                       (2.10) 
 
where τ is the shear stress, µ is the fluid viscosity v is the fluid velocity and y is the 
position along the height of the channel.  For rectangular shape channel, the shear stress 
can be described using the parallel plate model [71] 
wh
Q
2
6  ,                                                        (2.11) 
 
where Q is the volumetric flow rate, h is the height of the channel and w is the width of 
the channel.  As a result, shear stress is larger in smaller channels than larger channels.  
Depending on the cell type, the amount of shear stress that a cell can tolerate is different.    
In addition, fluid flow can lead to shear stress which can influence cellular behavior.  For 
example, shear stress can cause endothelial cells to polarize in the direction of fluidic 
flow  and can influence intracellular cAMP production in osteoblasts [76, 77]. 
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2.5.4 Surface Effects  
 As the device size shrinks from macro to micro, the surface area to volume (SAV) 
ratio increases dramatically.  The large SAV ratio would require attention to be paid to 
surface effects when designing microfluidic devices for cellular studies.  A 35 mm 
culture dish with 2.5 mL of media has a SAV ratio of 4.2 cm−1 [73].  On the other hand, a 
cylindrical micro culture chamber with diameter of 100 µm and height of 100 µm has a 
SAV ratio of 600 cm−1.   With the increase in surface area to volume ratio, some 
parameters have to be taken into account.  Proteins can be adsorbed to the surface and 
results in the depletion of proteins inside a microfluidic device.  Also, with the increase in 
surface area, evaporation happens at faster rate.   
 Another force that becomes prevalent is surface tension, which is a result of the 
attractive forces between the molecules inside the liquid.    Depending on the surface 
energy, liquid on solid/gas/liquid surface would result in different wetting behavior.  For 
example, if a droplet of water is formed on a solid surface and the attraction between the 
liquid surface and solid is strong, this would result in strong wetting of surface.  Such 
behavior is described as hydrophilic and the opposite effect, hydrophobicity can occur 
when the attraction between liquid and solid is not as strong as that in the liquid.  The 
wetting behavior is affected by the properties of the liquid.  For example, a more polar 
solvent such as water has stronger intermolecular bonding of the liquid molecules at the 
surface, and therefore, higher surface energy than ethanol.  The wetting behavior can be 
quantified using the contact angle θc, the angle between the liquid and solid surface [74].   
SGcLGSL   cos ,                                          (2.12) 
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where γSL, γLG, γSG, are the interfacial tensions of the solid/liquid, liquid/gas, and solid/gas 
interfaces, respectively. 
 As a result of surface tension, at the interface of liquid, solid, and gas, the surface 
of liquid is distorted, resulting in a pressure difference across the surface. Such pressure 
is described by the Young-Laplace equation [73]: 
)11(
21 RR
P   ,                                               (2.13) 
where ∆P is the pressure difference, γ is the surface tension of the liquid and R1 and R2 
are the principal radii of curvature. A spherical drop of liquid would have R1 = R2, 
resulting in  
R
P 2 .                                                     (2.14) 
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Chapter 3: 3-D Microfluidic Network Fabrication: Making 
Cell Culture Array on Silicon with Integrated 
Combinatorial Mixer 
 
3.1 Introduction  
 
 The ability to assess the combinatorial effects of several compounds on cells is an 
important aspect in the field of quantitative biology and drug screening.  As described in 
chapter 1, a mixture of drugs or chemical compounds can often treat diseases more 
effectively or act synergistically in certain cellular pathways, and many biological 
phenomena are governed by the combinatorial effects of several gene regulatory proteins 
or extracellular factors.  This is one of the reasons for the increase in demand for high-
throughput cell-based screening technology.  The popular method of using multi-well 
plates with robotics is limited by the problems of poor small-volume liquid handling 
ability, large consumption of reagents, and high cost of operation.  As discussed in 
previous chapters, microfluidic devices can overcome those problems and provide 
potentially inexpensive tools for high-throughput cell-based assays.  Microfabrication 
enables inexpensive chip platforms with high-density arrays to be mass fabricated.  
Performing cell culture and assays with microfluidic devices also possesses the 
advantages of increased throughput, precise liquid handling in the nanoliter range, and 
reduced sample volume.   
 While various on-chip culture systems have been developed, most of the current 
devices are designed to expose cells to a single compound at once.  The complexity of 
on-chip cell-based assay experiments can be greatly expanded by developing a cell 
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culture chip with an integrated combinatorial mixer to simultaneously deliver different 
combinatorial fluid streams to study cell cultures.  Additionally, a chip-based 
combinatorial mixer can decrease the time and labor during the process of mixing and 
dispensing solutions. Creating a combinatorial mixer requires the fabrication of three-
dimensional (3-D) microfluidic networks and different methods for creating 3-D 
microfluidic network will be described.  
3.1.1 Background of Three-Dimensional (3-D) Microfluidic Devices 
 
Previous methods of fabricating 3-D microfluidic devices often involved 
patterning and bonding of multiple layers.  Kikutani et al. fabricated 3-D microfluidic 
chip by bonding several etched glass substrates [78].  Pyrex glass was first covered with 
Cr and Au to protect the substrate during etching and positive photoresist was 
photolithographically patterned on top of the metal layer.  The Cr and Au were etched 
with I2/NH4I and Ce(NH4)2(NO3)6, and the glass was etched with 50% HF solution at a 
rate of 13 µm/min.  Then, the photoresist was removed with acetone, and the metals were 
removed using the I2/NH4I and Ce(NH4)2(NO3)6 solution.  Two glasses were patterned 
using this method for the top and bottom plates.  For the middle glass plate, through holes 
were drilled using ultrasonic sandblasting.  Finally, the glass plates were cleaned with 
ethanol and NaOH, and thermally bonded together inside a 650oC furnace for 5 hours.  
Patterned polyethylene terephthalate (Mylar D, Dupont, Washington, DC) can be bonded 
together to make a 3-D microfluidic network as demonstrated by Neils et al. [79].  The 
sheets were patterned with CO2 laser to create channels and windows.  Some sheets had 
dry adhesive coating (501FL, 3M), and the cut Mylar sheets were aligned, bonded and 
pressed to create the final microfluidic structures.  A total of 9 Mylar layers were stacked 
 
 
 
45 
together in this method.  PDMS (polydimethylsiloxane), a popular material for 
constructing microfluidic devices, has been used in 3-D microfluidic.  Jo et al. [80] 
presented a method to pattern and bond several 2-D PDMS layers to form complex 3-D 
channels.  To create the 2-D layers, PDMS prepolymer mixture was cast onto a master 
created by patterned SU-8 on silicon wafer and a transparency film was lowered onto the 
PDMS prepolymer mixture.   The stack was then clamped together with top and bottom 
flat aluminum plates, a Pyrex wafer and rubber sheet, and cured at 100oC for three hours.  
The 2-D layers were peeled off from the master, and the surfaces were cleaned with 
diluted HCl solution.  Finally, the layers were treated with oxygen plasma in reactive ion 
etching systems and aligned and bonded together.   
3.1.2 Motivations for Monolithic 3-D Microfluidic Fabrication 
 
While functional devices have been demonstrated, multilayer bonding process 
suffers several unavoidable drawbacks.  Performing the bonding process can result in 
possible misalignment from layer to layer and such process can be challenging to batch 
fabricate for large-scale production.  Furthermore, as the number of inputs for the 3-D 
microfluidic device increases, the number of layers can increase and result in an 
undesirably thick device.  Possible delamination of the layers and device failure can 
result from contamination of the surface.  In addition, many of the materials have not 
undergone extensive testing for biocompatibility and might not be suitable for cellular 
studies.  Therefore, a monolithic fabrication process using biocompatible material to 
build the devices would be desirable.  Such process should also have the capability to be 
scaled up to fabricate chip with large number of channels, inputs and outputs with only 
minor or no modification to the process.  
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This chapter will discuss the development of an integrated method to fabricate 
monolithic 3-D microfluidic networks and the fabrication of an on-chip cell culture 
device with an integrated combinatorial mixer based on such technology.  As a first 
example, the device has a combinatorial mixer with three inputs and one control channel.   
The combinatorial mixer is capable of generating the eight combinatorial streams 
simultaneously for delivery to the eight culture chambers.  Our fabrication method is 
based on the surface micromachining of Parylene C and can be scaled up to achieve high-
throughput combinatorial cell-based assays.  The packaging scheme to provide fluidic 
connection to the chip has been developed, and the capability to perform cell culture on 
this device has been demonstrated.  Finally, the integrated combinatorial mixer has 
successfully been used to expose cells to different combinations of compounds.   
 
3.2 Experimental 
3.2.1 Chip Design 
 
Figure 3-1 shows the device design layout.  In essence, the device has an array of 
culture chambers, where cells will be grown, and an integrated combinatorial mixer, 
which delivers different solution combinations to the culture chambers.  The array 
consists of 8 individually isolated micro culture chambers with cell loading inlets that 
enable cell introduction into the culture chambers.  Each culture chamber also has an 
outlet so fluidic samples can be collected.  The chamber dimensions are L 1500 µm × W 
700 µm × H 32 µm.  The chamber height of 32 µm is tall enough to accommodate a wide 
range of mammalian cells, as many of them have height around 10 µm.  The device has a 
combinatorial mixer with three inputs, and the combinatorial mixer recombines those 
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inputs into the seven possible outputs.  For example, compounds A, B, and C, will be 
recombined into A, B, C, A+B, A+C, B+C, and A+B+C.  Note that one control channel 
that receives an unmixed input stream is also included as the 8th output.  One key feature 
of the chip is the overpass structure that allows one microfluidic channel to cross over 
other microfluidic channels, and such fluidic network component makes the 
combinatorial mixer possible.  Solutions containing different compounds will be injected 
into the chip via the fluid inlets of the combinatorial mixer, and the outputted 
combinatorial streams will flow into the culture chambers. 
 
Figure 3-1. Layout of the device design showing the components of the 1 cm × 1 cm chip.   
 
The device is realized by the surface micromachining of Parylene C (poly(chloro-
p-xylylene)).  Several of the beneficial properties of Parylene C make it an ideal material 
for both 3-D microfluidic fabrication and constructing a cell culture and cell-based assay 
device.  Parylene C is compatible with lithographic CMOS/MEMS fabrication processes 
and our previous work has reported that multiple layers of Parylene C can be deposited 
and patterned to build complicated mechanical structures.  This will allow our 3-D 
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microfluidic device to be monolithically fabricated, favorably avoiding the multilayer 
bonding process.  Another aspect of this device is the ability to culture cells on-chip and 
Parylene C is suitable for this purpose.  Because Parylene C has been shown to be 
biocompatible and resistant to corrosive body fluids, it was used in many implantable 
devices [35, 36].  Long-term cell culturing using Parylene C devices have been 
demonstrated [81].  Also, Parylene C is chemically inert and stable toward many organic 
solvents [34].  In addition, Parylene C is transparent in the visible range and this will 
allow cells to be easily observed with light microscopy.   All these valuable properties of 
Parylene C make it the material of choice for fabricating our device.   
3.2.2 3-D Microfluidic Fabrication 
 
The device has two levels of microfluidic channels, and its five-mask fabrication 
process is shown in Figure 3-2.   The 3-D rendition of the process flow is also included to 
aid visualization.  The first-level channels were initially deposited, followed by the 
deposition of the overpasses and culture chambers.  The device was fabricated using our 
developed Parylene surface micromachining technology: alternating layers of Parylene C 
and sacrificial photoresist are deposited, and the sacrificial photoresist between two 
layers of Parylene defines the channel.  After the photoresist is removed, the remaining 
hollow Parylene structures become the fluidic networks of the chip. 
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Figure 3-2. The monolithic fabrication process for making the three-dimensional 
microfluidic networks.  (a) Cross sectional view of the fabrication process flow.  (b) Three-
dimensional rendition of the fabrication process flow.  Inserts in (2) and (4) show how the 
overpass is made by first etching open the Parylene and joining the two etched regions with 
the 2nd sacrificial photoresist.   
 
The detailed fabrication process can be broken down into the following steps. 
First layer Parylene coating. Before any processing, the silicon wafer was cleaned with 
Piranha solution (H2SO4: H2O2, 3:1) at 120oC for 5 min.  The wafer was then soaked in 
0.5% silane A-174 (gamma-methacryloxy-propyltrimethoxysilane, Specialty Coating 
(a) 
(b) 
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Systems, Indianapolis, IN) solution (DI water: isopropyl alcohol: A-174, 100:100:1) for 
15 minutes to promote the adhesion between the substrate and Parylene C.  The Piranha 
treatment not only cleaned the surface, but also oxidized the substrate surface.  The 
oxidized surface facilitated the binding of the adhesion promotion A-174 molecule onto 
the surface.  The chemical structure of the A-174 silane coupling agent follows the 
general structure of silane-based coupling agents: RnSiX(4-n).  R is the nonhydrolyzable 
organic moiety that binds to the coating polymer, which is Parylene C in our case.  The X 
represents alkoxy moieties, and is methoxy in A-174.  During the treatment, the methoxy 
group is hydrolyzed to methanol, forming hydroxyl group that can form hydrogen 
bonding with hydroxyl group on the substrate.  Eventually, covalent Si-O bonding is 
formed in between the substrate and the coupling agent [82].   The other side of the silane 
molecule serves to grab onto the Parylene molecules to promote the adhesion onto the 
surface.  After the treatment, a first thin adhesion layer of Parylene C was deposited (3 
µm) to cover the entire wafer with a Cookson Electronics PDS 2010 system (Specialty 
Coating Systems, Indianapolis, IN).   The subsequent deposited Parylene layers in the 
following processes are attached to this first Parylene layer instead of the silicon substrate 
and this is important because Parylene adhesion to silicon without proper treatment can 
be very weak.  A-174 adhesion promoter cannot be applied for the subsequent Parylene 
depositions because when there are photoresist patterns on the substrate, isopropyl 
alcohol inside the treatment solution will quickly dissolve the photoresist.   
First layer channel.  The first sacrificial photoresist layer (AZ4620 from Clariant, 
Charlotte, NC) was spin-coated (15 µm) and patterned with photolithography to define 
the first-level channels.  The sacrificial photoresist was hard baked at 120oC for 6 hours.  
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To promote adhesion of the next Parylene layer to the first Parylene layer, the surface 
was roughened using oxygen plasma and cleaned with 5% HF for 30 seconds.  A second 
layer of Parylene C (10 µm) was then deposited to cover the sacrificial photoresist to 
form the first-level channels.   
Parylene patterning.  Parylene C was patterned using oxygen plasma so the areas where 
the overpass structures would be joined were exposed.  This Parylene patterning also 
opened the area where the mixer and the culture chamber would be connected.   To 
pattern the Parylene, metal mask was used because oxygen plasma can also etch 
photoresist at a rate comparable to Parylene etching, so a very thick photoresist would 
have to be used.   Also, when striping the masking photoresist, the sacrificial photoresist 
can be partially dissolved and this can lead to debris clogging the channel or trapped air 
expanding and destroying the channel during subsequent thermal processes.  Cr/Au 
(200/2500Å) layer was deposited using an e-beam evaporator.  To pattern the metal, a 
15 µm AZ4620 photoresist was patterned on top of the metal, and the metals were etched 
using Au etchant type TFA (potassium iodide (KI) + iodine (I2)) (Transene, Danvers, MA) 
and CR-7 Cr etchant (9% ceric ammonium nitrate + 6% perchloric acid  in water) 
(Cynateck, Freemont, CA) . The photoresist was stripped using acetone.  The Cr/Au 
metal layer was then used as an etch mask for Parylene patterning in oxygen plasma.  The 
metals were stripped after Parylene patterning.   
Second layer channel.  A second sacrificial photoresist was spin-coated (32 µm) and 
patterned to define the overpass structures and the culture chambers.  This second 
sacrificial photoresist covered the etched open areas, and the overpasses spanned several 
of the first-level microfluidic channels.  A third layer of Parylene C (10 µm) was 
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deposited after the same adhesion promotion treatment procedure as described in 
previous steps.  This Parylene was patterned using metal as mask and oxygen plasma 
etching.   
SU8 planarization and chip release.  The whole chip was strengthened and planarized 
with patterned 100 µm SU8 (MicroChem, Newton, MA) to facilitate the following 
packaging of the chip.  The wafer was diced to yield chips with dimensions of 1 cm × 
1 cm.  Finally, the chips were soaked in 65oC IPA (isopropyl alcohol) to dissolve the 
sacrificial photoresist in about one week. 
3.2.3 Device Packaging and Fluidic Testing 
A packaging scheme was developed to make the fluidic connections with the chip 
as shown in Figure 3-3.  A slab of cured PDMS (4 mm thick) (Sylgard 184, Dow Corning, 
Midland, MI) with punched holes was aligned onto the chip.  The PDMS and the chip 
were clamped together by two pieces of transparent acrylic that were milled with a 
computer-numerical-controlled (CNC) machine.  The PDMS acted both as a gasket layer 
to provide proper sealing and as an adapter to connect the tubes.  Syringes were 
connected with Teflon tubes, which had metal hollow tube (0.025 inch OD × 0.013 inch 
ID × 0.250 inch length) (New England Small Tube, Litchfield, NH) inserted at one end, 
and plugged into the ports of the piece of PDMS.  Depending on different fluidic 
operations on the same device, the holes of the PDMS piece can be adjusted as open or 
blocked at different places to either open or close certain access holes on the chip.   
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Figure 3-3. Schematic representation of the packaging method for making fluidic 
connection. 
 
To solely test the combinatorial mixer on the fabricated device, the chip was 
packaged with holes open at the combinatorial mixer inlets and outlets, while the cell 
loading inlets were closed as illustrated in Figure 3-4.  Green, red, and blue food coloring 
solutions were injected into the three inputs of the combinatorial mixer, and yellow food 
coloring was delivered into the control channel.  Arrows in Figure 3-4 show that two 
fluid streams are separated spatially at the overpass region and flow in two different 
directions ( and ).  The food coloring solutions were loaded into syringes and the 
flow rate was controlled by programmable syringe pumps (Harvard Apparatus, Holliston, 
MA).  Pictures of the experiment were taken with a stereoscope equipped with a CCD 
camera (Diagnostic Instrument, Sterling Heights, MI).  
 
Figure 3-4. Chip packaged for testing the combinatorial mixer. 
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3.2.4 Testing Parylene C as Suitable Substrate for Cell Culture 
 
Tests were first performed to verify that Parylene C is a biocompatible substrate 
for our specific cell culture.  Three culture substrates were used in this experiment: (1) 
unmodified standard polystyrene petri dish (VWR Scientific, West Chester, PA), (2) petri 
dish coated with Parylene C, (3) petri dish coated with Parylene C and pretreated with 
0.05% polyethyleneimine (PEI) in borate buffer solution.  For samples (2) and (3), 5 µm 
Parylene C was deposited on 60 mm polystyrene petri dishes.  Some petri dishes were 
further treated with 0.05% PEI solution for 24 hours, followed by rinsing with PBS three 
times before culturing.  PEI solution has been shown to enhance cell adhesion to culture 
substrates [83].  B35 rat neuroblastoma cells were purchased from ATCC (Manassas, 
VA), and cultured in Dulbecco’s Modified Eagle’s Medium (Invitrogen, Carlsbad, CA) 
with 10% fetal bovine serum and 1% penicillin/streptomycin/amphotericin B.  To assess 
the growth rate of cells on the different substrates, B35 cells were seeded onto the 60 mm 
petri dishes at an initial concentration of 6 × 104 cells mL−1 and the cell concentrations 
were recorded again 24 hours after cell seeding.  The cell growth rate was modeled using 
the exponential model: N(t) = No × exp(µt), where N is the cell concentration, No is the 
initial cell concentration, t is the culturing time and µ (hour−1) is the specific growth rate. 
By culturing the cells through certain duration, tf, and measuring the starting and final 
cell concentration, No and Nf, the specific growth rate, µ (hour-1), can be derived as         
µ = ln(Nf/ No)/ tf. 
3.2.5 Microfluidic Cell Culture 
 
Cell culture was done on-chip to test if the Parylene-based culture chamber can 
sustain cell growth.  B35 rat neuroblastoma cells were cultured in 100 mm × 15 mm 
 
 
 
55 
polystyrene petri dishes and passaged every two to three days.  The cells were maintained 
in Dulbecco’s Modified Eagle’s Medium with 10% fetal bovine serum and 1% 
penicillin/streptomycin/amphotericin B, and incubated in 5% CO2 at 37oC.  Cells were 
cultured on the chip using the following method.  To culture the cells inside micro culture 
chambers, we assembled the device packaging with the cell loading inlets and outlets 
open, as shown in Figure 3-5.  Before loading the cells onto the chip, the chip was 
sterilized by UV irradiation in addition to treatment of all the fluidic channels and culture 
chambers with 70% ethanol solution.  After the ethanol solution was rinsed out with 
phosphate buffered saline (PBS) solution, the culture chambers were treated with 0.05 % 
polyethyleneimine (PEI) in borate buffer solution for 24 hours to enhance cell adhesion 
to the culture chamber.    The PEI solution was subsequently rinsed out with PBS.  Cells 
were suspended from petri dishes and delivered into the culture chambers with a syringe.  
The cells were allowed to settle and attach to the culture chamber surface for four hours.  
With the flow rate controlled by syringe pumps, cells were cultured with continuous 
perfusion of culture media at the flow rate of 33 nL min−1.  During the culture experiment, 
the device was kept inside an incubator that was set at 37oC and 5% CO2.  Cell growth 
was monitored periodically with a Nikon E800 upright microscope. 
 
Figure 3-5. Schematics showing the device operation procedure for the on-chip cell 
culture experiment.   
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3.2.6 Integrated Combinatorial Mixer for Cell Treatment 
 
A straightforward experiment was performed using the integrated combinatorial 
mixer for cell treatment.  The device was assembled with all the inlets and outlets open, 
as shown in Figure 3-6.  Cells were injected into the culture chamber following the same 
procedure as in cell culturing.  After the loaded cells attached to the chamber surface, we 
injected three different cell staining solutions: 0.005% w/v crystal violet, 0.016% w/v 
neutral red and 0.01% w/v methylene blue through the combinatorial mixer channels.  
Crystal violet solution (0.5% w/v crystal violet with 10% ethanol and 0.8% ammonium 
oxalate) and methylene blue solution (1% w/v in water) were purchased from The 
Science Company (Denver, CO) and neutral red solution (neutral red 1.0 g/L, acetic acid 
2 mL/L in water) was purchased from Sigma-Aldrich (St. Louis, MO).  The cell staining 
solutions were diluted to the indicated concentration with phosphate buffered saline (PBS) 
solution.  No fluid was injected into the control channel.  The stain loading was 
controlled by syringe pumps and was set at 30 µL min−1 for a duration of 10 minutes.  
Pictures of each culture chamber were taken 30 minutes after the flow was stopped.  With 
the above operation, cells in different culture chamber received different combination of 
stains, and the cells in the control chamber did not receive any staining solutions.   
 
Figure 3-6. Schematics showing the device operation procedure for cell assay with 
combinatorial mixer. 
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3.3 Results and Discussion 
3.3.1 Device Fabrication and Combinatorial Mixer Testing 
 
 
 
Figure 3-7. Monolithically fabricated microfluidic cell culture array with an integrated 
combinatorial mixer.  (a) Fabricated 1 cm × 1 cm chip.  (b) SEM image of the cross 
section of the microfluidic overpass.  The overpass has two-level microfluidic channels 
and such structures will allow two fluidic streams to be separated spatially at the overpass.  
(c) Surface height profile scan of the overpass region before SU8 planarization.  The 
overpass structure is about 15–20 µm higher than the first-level microfluidic channels. 
 
 Figure 3-7(a) shows the fabricated chip having a dimension of 1 cm × 1 cm with 
a thickness of approximately 672 µm.  One characteristic of monolithic fabrication is that 
it yields devices which are typically thinner than devices fabricated using multilayer 
bonding process.  Both Parylene and SU8 are transparent and experiment can be easily 
observed with a microscope from the top side of the chip.  It is also possible to release the 
device from substrate by either adding a sacrificial photoresist before the first layer 
Parylene deposition or skipping the A-174 adhesion promotion step and the chip will 
(a) 
(b) (c) 
 
 
 
58 
separate from the substrate after soaking in acetone [84].  This will result in a thin and 
flexible microfluidic device and the flexibility can be useful for implanting devices into 
animal or human bodies.    
 By using the bi-level sacrificial photoresist process, channels of different heights 
(15 and 32 µm) were successfully created.  This enables overpass to be created and 
allows the higher microfluidic channel to cross over the shallower microfluidic channel.  
We examined the fabricated microfluidic overpass by taking SEM images of the cross 
section of the overpass structures.  Figure 3-7(b) shows the two-level microfluidic 
channels and such a structure could allow two fluidic streams to be separated spatially at 
the overpass region.  The microfluidic channels are semi-circular in shape because the 
sacrificial photoresist was hard baked.  The adhesion promoter, silane-based A-174, led 
to a strong adhesion of the first layer Parylene to the substrate.  The subsequent Parylene 
adhesion was strengthened by roughening the surface using oxygen plasma to increase 
the effective bonding area and a thorough cleaning with HF to ensure a contaminating-
free surface.  The SU8 further strengthened the bonding of the underlying Parylene layers 
to the substrate.  As a result, the chip was able to withstand release in isopropyl alcohol 
without delamination.   The SU8 also planarized the surface so sealing material such as 
PDMS gasket layer or o-rings can be placed directly onto the chip surface without 
destroying the delicate microchannels.  Figure 3-7(c) shows the surface profile scan (P-15 
stylus profilometer from KLA-Tencor, San Jose, CA) of the overpass structure before 
SU8 planarization, and it shows that the overpass structure is about 15 µm higher than the 
first-level microfluidic channels.  This monolithic fabrication has allowed us to fabricate 
our chips without additional multilayer bonding.  It is possible to create combinatorial 
 
 
 
59 
mixer with even more inputs and outputs by following the same fabrication steps.  
Additional overpasses can be placed in to accommodate the routing of the microchannels.  
This is similar to laying down all the wires in a basic circuit diagram that numerous wires 
can be drawn on a 2-D space by using the cross over symbols.   The successful 
development of this method lays the foundation to build more complicated 3-D 
microfluidic devices.  
 Our proof-of-concept combinatorial mixer was able to take in the three input 
streams of food colorings (red, green, and blue) and generated the seven possible 
combinations, as shown in Figure 3-8.  The input flow rate of the food coloring injection 
was controlled by syringe pumps and experiments at two different flow rates were shown.  
The control channel received only the yellow food coloring that was not mixed with any 
other solutions.  Figure 3-8(a) shows the assembled device with appropriate tubes 
plugged in, and our scheme of packaging has worked without any fluid leakage.  This 
packaging method is uncomplicated as the PDMS slab can be quickly prepared in-house 
and holes be readily punched in.  Only a simple rectangular pattern has to be machined 
on the acrylic to provide access spaces for the tubes.  Plugging Teflon tubes into PDMS 
ports has been standard in various PDMS microfluidic devices.  This packaging scheme 
is suitable for cell-based application as no high pressure environment will be required.   If 
high operating pressure is required (>100 psi), plugging tubes into the PDMS will not 
hold at such pressure, and other packaging scheme has to be used.  One packaging 
method is to use o-rings or gaskets and machined manifold to connect to high pressure 
fittings [44].  Figure 3-8(b) and Figure 3-8(c) show that the overpass structures enable 
one fluidic stream to flow over several other microchannels.  In microfluidic devices, the 
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Reynolds number is usually low so the fluid flows at micro scale are laminar.  As a result, 
mixing occurs by diffusion alone and flow rate becomes an important factor that affects 
the homogeneity of the mixture.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-8. Combinatorial mixer demonstration.  (a) Assembled device with food 
coloring being injected.  Green (G), red (R) and blue (B) food coloring solutions are 
injected into the combinatorial mixer inlets, while the yellow (Y) food coloring solution 
is injected into the control channel.  Combinatorial mixer operated at two flow rates: (b) 
10 µL min−1, (c) 0.1 µL min−1.  The scale bar represents 1 mm.  
 
 Figure 3-8(b) shows the combinatorial mixer at an input flow rate of 10 µL min−1, 
and the stripes from the input streams of food coloring solutions are still visible at the end 
of the serpentine channels.  However, even though the mixture is not homogeneous, the 
correct combinations of fluid streams are still generated.  Figure 3-8(c) shows the 
(a) 
 
(b) 
 
(c) 
1 cm 
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combinatorial mixer at lower flow rate, 0.1 µL min−1, and as flow rate goes down, 
molecules have more time to diffuse across the channel for better mixing.  At the flow 
rate of 0.1 µL min−1, the stripes of the input fluid streams are no longer visible at the end 
of the serpentine channel.  One can understand this effect conceptually by considering a 
T-junction mixer with two fluid streams flowing alongside each other.  The time, t, for a 
molecule with diffusion coefficient, D, to diffuse across a channel with width w, can be 
estimated as t ~ w2/D.  With a fluid velocity of U, the molecule will travel down the 
channel with a distance Z during that time period, and Z ~ Uw2/D [74].  This expression 
indicates that as flow rate increases, the stripes will travel longer distances before they 
are completely mixed with each others.  The serpentine channel helps mixing by giving 
the molecules more time to diffuse across the channel before they reach the outlet.   
Our fabrication method offers the opportunity for scaling up the number of inputs 
for the combinatorial mixer.  More inputs can be incorporated using the same method of 
first laying down the first-level channels, followed by the making of the overpasses.  As a 
result, even when the number of inputs and outputs increase, the complexity of 
fabrication does not increase substantially.  In addition, a combinatorial mixer with a 
diluter can be fabricated using the same fabrication process.  Typical biological assays 
often include multiple dilutions of compounds to assess the concentration-dependent 
cellular responses to certain compounds.  To realize such a device, we can incorporate a 
concentration gradient generator into each of the inputs, and each of the input streams 
will be diluted into sub-streams with different concentrations.  Those streams of dilutions 
can be recombined in 3-D microfluidic networks, which can be constructed using the 
same method as our current fabrication process.    
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3.3.2 Parylene C as a Substrate for Cell Culture  
 
The cell chamber of the chip is composed of Parylene C and we performed a 
biocompatibility testing to verify that cells can grow properly on Parylene C surfaces.  
B35 rat neuroblastoma cells were grown on three different substrates: (1) unmodified 
standard polystyrene petri dish, (2) petri dish coated with Parylene C, and (3) petri dish 
coated with Parylene C and pretreated with 0.05% polyethyleneimine (PEI) solution.  The 
cell growth rates on the prepared substrates are plotted in Figure 3-9.  The result shows 
that the growth rates on all three substrates are similar.  The growth rate on untreated 
Parylene appeared to be slightly lower and this can be due to the lack of proper cell 
anchoring to the substrate.  PEI is consisted of many positively charged amine groups and 
can help attract the negative charged surface molecules on the cell membrane.  These 
results show that Parylene C is a biocompatible substrate for cell culturing and is a 
suitable material for constructing micro culture chambers.  Other types of cells such as 
hippocampal CA1 and CA3 pyramidal cells, NIH-3T3 fibroblasts and AML-12 
hepatocytes have also been shown to grow on Parylene C substrate [81, 85]. 
 
Figure 3-9. B35 cell growth rates on three different substrates:  (1) unmodified standard 
polystyrene petri dish, (2) petri dish coated with Parylene C, (3) petri dish coated with 
Parylene C and pretreated with 0.05% polyethyleneimine (PEI) in borate buffer solution 
before cell seeding.  Results are the means ± standard deviation (SD).  (n = 3). 
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3.3.3 Microfluidic Cell Culture 
 
Cell culture inside the micro culture chamber was performed using B35 rat 
neuroblastoma cells to test that the microfluidic chip could sustain cell growth.  The 
culture chamber was treated with PEI solution to enhance cell adhesion before cell 
seeding.  Cell suspension was delivered into the chip with a syringe and a static condition 
was followed to allow the cells to adhere to the surface.  This step is important that 
without proper cell adhesion to be made to the surface, the cells would flow away when a 
flowing condition is introduced.  The cells were grown with a continuous perfusion of 
media at 33 nL min−1 inside a 37oC incubator.  At this flow rate, the content of the culture 
chamber was turned over at approximately once every minute so cells would not be 
deprived of nutrients.  Gas can pass through the PDMS, which is highly permeable to 
oxygen (diffusion constant, D = 3.4 × 10−9 m2 s−1) and enter the chip via any of the access 
holes on-chip.  Figure 3-10 shows finite element analysis of oxygen transport using the 
combined transient diffusion/convection model and incompressible Navier-Stokes model 
in Comsol Multiphysics (Comsol, Burlington, MA).  The culture media flows in through 
the inlet at 2 × 10−6 m/s and the oxygen can enter through the PDMS.  The fluid velocity 
profile was solved first and the stored solution was used to solve for the concentration 
profile in the diffusion/convection module.  The diffusion constant of oxygen in water is 
2.1 × 10−9 m2 s−1.  Result shows that oxygen can readily pass through the PDMS and 
enter the culture chamber.   
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Figure 3-10. Simulation of oxygen transport through the PDMS into the chamber.  (a) 
Configuration used for the simulation.  Fluid is delivered from the inlet and the oxygen 
can enter through the PDMS.  Oxygen concentration at various times: (b) 1800 s, (c) 
3600 s, and (d) 7200 s.   
 
Figure 3-11 shows that cells proliferated inside the micro culture chambers and 
eventually reached confluency after 42 hours of culturing.  The calculated cell growth 
rate was 0.018 hr−1.  This study shows that cells can be sustained inside the Parylene C 
microfluidic cell culture chambers.   
 
 
 
 
 
 
Figure 3-11. Cell culture inside Parylene C micro culture chamber. 
 
4 hours 16 hours 42 hours 
300 µm 
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3.3.4 Integrated Combinatorial Mixer for Cell Treatment  
 
The combinatorial mixer was used to perform a cell treatment and the result is 
shown in Figure 3-12.  The chip was first packaged with all of the access holes open, and 
the device was operated as shown in Figure 3-6.  B35 cells were seeded by injecting them 
through the cell loading inlets of individual chambers, and the cells attached to the 
culture chamber surface after four hours.  Following cell adhesion, three cell stains, 
crystal violet, methylene blue and neutral red were injected through the combinatorial 
mixer inlets, while no solution was injected into the control channel.  The combinatorial 
mixer recombined the input streams and simultaneously delivered the various 
combinatorial streams into the cell culture chambers.  Cells in different culture chambers 
received different combinations of the stains and were stained with different color 
patterns, while the cells in the control chamber were unstained.  This experiment shows 
that we can use the on-chip combinatorial mixer to simultaneously interrogate individual 
culture chambers, and each group of cells inside the different culture chamber received 
different inputs and showed distinct responses.  Eight different combinatorial conditions 
were created simultaneously, saving the extra pipetting steps.  This preliminary study lays 
the foundation to perform experiments with longer duration and enhanced complexity 
involving cell growth under continuous perfusion of different combinatorial culturing 
solutions.  Besides monitoring cell growth, more complicated cellular response or signal 
pathways such as gene expression can be studied on the current chip by integrating 
existing biological technologies.  Real-time monitoring of gene expression on 
microfluidic chips has been demonstrated using a fluorescent transcription reporter, and 
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we can monitor the cellular response using similar methods by loading transfected cells 
into the culture chamber [70].   
 
 
Figure 3-12. Cell treatment using the integrated combinatorial mixer. 
 
3.4 Conclusion  
 
In this chapter, we presented a monolithic fabrication technology of an integrated 
combinatorial mixer for cell assay, and showed the ability to simultaneously treat arrays 
of cells with different combinations of compounds.  Our fabrication method enables 
devices to be conveniently fabricated at the wafer scale.  Fabricated using a scalable five-
mask process with Parylene C as the structural material, the device can simultaneously 
provide eight combinatorial medium outputs to study cell cultures.  The microfluidic 
overpass structure allows one microfluidic channels to cross over other microfluidic 
channels, and using similar fabrication process, the number of inputs and outputs of the 
combinatorial mixer can be scaled up for high-throughput cell-based assay.  Such device 
can efficiently collect large quantities of information pertaining to cyto-regulation and 
elucidate combinatorial effects of multiple compounds on cells.  Furthermore, our 
fabrication technology can enhance the functionalities of current lab-on-a-chip devices by 
integrating the devices with complex 3-D microfluidic networks.  The fruition of such 
300um 
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system will enable lab-on-a-chip devices to perform highly parallel and combinatorial 
chemical or biochemical reactions with reduced labor, reagents, and time.  
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Chapter 4: Combinatorial Cell Assay Device on Glass 
with Membrane-Based Cell Culture Chamber 
 
4.1 Introduction  
 
With the successful development of the monolithic fabrication of 3-D 
microfluidic networks, the next step is to improve device design to facilitate cell-based 
assay on-chip.  One of the improvements is to simplify the experimental procedure and 
make the device more user-friendly.  Microfluidic devices are often complicated to 
fabricate and it is important to make them easy to use for end users.  Also, most modern 
cell culture and assay platforms such as multi-well plates are based on transparent 
substrates such as glass or polystyrene plastics, and it would be ideal to construct 
microfluidic devices based on glass.  Finally, it would be advantageous to improve the 
cell culture chamber design to mimic the in vivo cellular microenvironment.   
While there have been a plethora of microfluidic cell culture and assay devices 
being created, many of them did not take full advantages of microfluidic-based systems.  
One advantage that microfluidic offers over traditional culture container such as petri 
dish is the ability to control the cellular microenvironment.   Micro scale devices have 
characteristic length scale of 0.1–100 µm, which is the same as the microenvironment 
that the cells reside in.  Therefore, microfluidic device has the ability to create culture 
environment that mimics the in vivo microenvironment and provide assay results that can 
be more biologically relevant than tradition culture platforms.  The cell 
microenvironment is comprised of several complex factors.  One important parameter in 
cell microenvironment is fluid flow as it provides a way to transport important factors 
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such as nutrients, wastes, oxygen, and various soluble factors to and from cells.  
Depending on the cell locations, different cells are exposed to different range of flow rate 
inside our body.  Endothelial cells lining the wall of aorta can experience flow rate up to 
as much as 300,00 µm/s, while interstitial flow at the capillary level is at 0.1–1 µm/s 
range [86].  Microfluidic devices have been created to study the influence of shear stress 
on cells and the laminar nature of the microfluidic flow and the ability to easily control 
flow and monitor cell behavior simultaneously have made microfluidic device very 
suitable for such studies.   While certain cells require constant shear stress to prosper, it is 
important to note that high shear stress level can be detrimental to certain cell types [68].  
This is an especially important aspect to be considered during microfluidic cell culture 
design as perfusion will inevitably introduce shear stress to cells and most microfluidic 
cell culture devices utilize perfusion to deliver nutrients and other soluble factors to the 
cells.   
 While cells such as endothelial cells that line the wall of blood vessel are directly 
exposed to fluid flow and share stress, most cells inside the tissues are residing in a space 
that is shielded from convective flow.  Fluid flow inside such environment is minimized 
while transport is dominated by diffusion [69].  The Peclet number, Pe, is the ratio that 
indicates the relative importance of convection to diffusion and is defined as 
D
vlPe  ,                                                                (4.1) 
 
where v is the fluid velocity, l is the characteristic length and D is the diffusion constant.  
Inside the tissue, the Peclet number is about 0.1 and the shear stress is about 0-2 Pa [69].  
While traditional cell culture on flat petri dish or well plate substrate provides a low shear 
environment for the cells, the cells are subject to very different condition than cellular 
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microenvironment inside the tissue.  The longer length scale and larger volume of the 
macro scale cultures allow for chaotic flow.  While this allows for better mixing, it can 
disturb soluble factor patterns that can only be established with laminar flow.  Another 
significant difference is that cells inside the tissue reside in a 3-D environment and can 
receive fluid from both top and bottom sides of the cells.  Cells cultured on a flat 
substrate are limited to only receive extracellular factors from one side.   Microfluidic 
technology can address those problems and create culture space that has precisely 
controlled flow conditions and better mimics the in vivo microenvironment. 
 While the potential utility of microfluidic devices is clear, there are various 
barriers that can present challenges for microfluidic devices to be adopted by biologists.  
Some issues that have to be addressed are the ease of use and integration with current 
laboratory equipments and techniques.  It is important that the device design does not 
involve excess complexity and be suitable for the end users to operate.  Our first-
generation chip described in the pervious chapter has some improvements that can be 
made.  The device was fabricated on silicon substrate and this can make it difficult for 
observation under microscopy.  Such setup requires light to be illuminated from the same 
side as the objective for imaging the device, but many microscopes have light source on 
the opposite side of the objective.  Also, the fluids are delivered from the top side because 
using patterned SU8 and etched Parylene as open ports is simpler for fabrication than 
performing through-wafer etching for ports from the bottom side.  However, because 
such setup requires tubes to be plugged in from the top side, the overall device thickness 
is increased and a long working distance objective has to be used.  This also limits the 
resolution of the objectives that can be used as high resolution objectives generally have 
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short working distance.  Therefore, using a glass substrate for the device would be more 
ideal and imaging can be performed with minimal fluorescence interference.  Proper cell-
based assay can be designed so the readout can be done directly on-chip to simplify the 
experiments.   
 Another possible area for improvement is the cell loading procedure.  The first-
generation chip required channel walls to be treated with adhesion promoting factors 
before cell loading.  Also, the cell loading was not very efficient as many cells were 
flushed through the channel before enough cells were captured inside the culture chamber.  
Furthermore, the previous design required that cells be loaded into each chamber 
separately.  While doing so only required relatively short amount of time because only 
eight chambers were included on that chip, this can be a significant problem when the 
device is scaled up to include more chambers.  It would be ideal to design a chip that 
incorporates an efficient and user-friendly cell loading process.   
In this chapter, the development of 3-D microfluidic networks on glass substrate 
for cell-based assays with multiple combinations of compounds is presented.  The final 
assembled device is composed of a porous membrane integrated in between a multilayer 
Parylene 3-D microfluidic chip and a PDMS microfluidic chip.  The methods to improve 
cell loading efficiency and to simplify the cell loading procedure are demonstrated.  The 
culture chamber incorporates a bi-level design to mimic the cellular microenvironment in 
vivo where the cells reside in a diffusion dominated space separated from convection 
dominated blood vessels.  In our previous chapter, we have discussed the method to 
monolithically fabricate three-dimensional (3-D) microfluidic networks on silicon 
substrate.  The developed fabrication process was based on the surface micromachining 
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of Parylene C (poly(chloro-p-xylylene)) and eliminated the need for the bonding steps as 
in many other  multilayer microfluidic devices.  The device presented in this chapter is 
fabricated based on the extension of such procedure.  We have characterized 
concentration distribution of each output from the combinatorial mixer by using a 
fluorescence method.  Two quantitative cell-based assays were performed using this 
device.  We cultured rat neuronal cells, B-35, on this device and screened for the ability 
of three chemicals to attenuate cell death caused by cytotoxic hydrogen peroxide.  We 
also assayed for the combinatorial effects of three chemotherapeutic compound exposures 
on human breast cancer carcinoma, MDA-MB-231. 
 
4.2 Experimental  
4.2.1 Device Design 
 
The schematic of the assembled microfluidic device is shown in Figure 4-1.  The 
device is composed of a porous PET (polyethylene terephthalate) membrane sandwiched 
in between the two microfluidic chips: a 3-D microfluidic Parylene C (poly(chloro-p-
xylylene)) chip with integrated combinatorial mixer, and a PDMS (polydimethylsiloxane) 
chip with one-to-eight manifold and cell culture chambers.   
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Figure 4-1. Schematics of the microfluidic device.  (Left) 3-D rendition of the device 
before assembly.  (Right) Side view of the device. 
 
Figure 4-2 shows the layout of the 1.7 cm × 1.7 cm 3-D microfluidic Parylene-
based chip with integrated combinatorial mixer.  The combinatorial mixer has three 
inputs, which are recombined into the seven possible outputs. An unmixed control 
channel is also included.  Like the chip described in the previous chapter, the overpass 
structure allows one microfluidic stream to cross over other microchannels, and a control 
channel that receives none of the three inputs is included.  Unlike the previous chip, glass 
wafer will be used as the substrate instead of silicon.  The chamber diameter is 1 
millimeter.   The 3-D microfluidic Parylene chip is consisted of two different layers of 
microfluidic network, with the bottom 14 µm height channels making up the basic 
combinatorial mixer channels and the top 25 µm height channels making up the 
overpasses and the outlet channels.   
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Figure 4-2. Layout of the 3-D microfluidic Parylene-based chip. 
 
Compounds A, B, and C are delivered into eight chambers with different 
combinations and concentrations, and the concentration of each compound inside the 
chamber is determined by the fluidic resistance of the channels.  As the channel width is 
much larger than the channel height, the resistance can be modeled using the simplified 
formula for rectangular channel:  
3
12
wh
LR  .                                                            (4.2) 
 
R is the resistance, µ is the fluid viscosity, and L, w, and h are the length, width and 
height of the channel, respectively.  Chambers receiving multiple compounds are 
designed to have equal dilution of the input compounds.  For example, chamber 2 is 
designed to be 50% of input A and 50% of input B so the channel connecting input A and 
chamber 2 (channel AII) and the channel connecting input B and chamber 2 (channel BI) 
would have the same fluid resistance. As the channel heights are the same for all the 
channels in the combinatorial mixer, the channel widths and lengths are tuned to achieve 
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the desired flow resistance.  The fluidic channels can be represented as network of fluidic 
resistors and the schematic is shown in Figure 4-3. 
 
Figure 4-3. Equivalent fluidic resistance network of the chip. 
 
 In addition, the fluidic networks are designed so the flow rate into each chamber 
is the same to prevent variation in shear stress that can affect the cells.  This is done by 
making the combined fluid resistances leading up to each chamber to be the same.   Thus, 
the fluidic resistances of channels, AI, BII, CIV, and N, which lead to chambers with single 
compounds, would be the same.  The fluidic resistances of channels leading to chambers 
with two compounds are twice of the fluid resistances of channels leading to chambers 
with single compounds.  For example, channels AII and BI, which connect input A to 
chamber 2 and input B to chamber 2, respectively, would have twice the fluidic resistance 
of channel AI.  The fluidic resistances of channels leading to chambers with three 
compounds are three times of the fluid resistances of channels leading to chambers with 
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single compounds.  The flow rate, Q is related to the pressure drop, ∆P, and fluidic 
resistance, R, by the following equation, 
R
PQ  .                                                         (4.3) 
 
With a constant flow rate source (syringe pump) delivering a flow rate, QO, into each 
input, Q1, the flow rate into chamber 1, which receives a single compound, would be 
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R[ATOTAL] is defined by the following equation: 
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R represents the resistance and the name inside the square bracket indicates the specific 
channel.  For example, R[AI] is the fluidic resistance for channel AI.  The expressions for 
][ TOTALBR  and ][ TOTALCR  follow same expression as equation 4.5.   
Q2, the flow rate into chamber 2, would be the combined flow rate of flow through 
channel AII and channel BI: 
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As stated above, 
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Thus, the two chambers, chamber 1 and chamber 2 would receive the same flow rate of 
3/7QO.  The designs for all the other channels follow the same principle so the flow rates 
into all the chambers would be equal and the chambers receiving two or more inputs 
would have equal flow rate from each of the connecting channels.   
Figure 4-4 shows the layout of the 2.5 cm × 2.5 cm PDMS microfluidic chip with 
100 µm height channels.  It has punched holes that match the locations of the ports on the 
Parylene microfluidic chip.  The PDMS piece also has a cell loading inlet and a one-to-
eight manifold that distributes cells or reagents into eight chambers simultaneously.  In 
addition, the chamber locations of the PDMS chip align to the locations of the culture 
chambers of the Parylene microfluidic chip.  At the cell culture chamber area, a 0.5 cm × 
1.5 cm transparent PET (polyethylene terephthalate) membrane with 0.4 or 1.0 µm 
diameter pores is sandwiched in between those two chips, and the membrane separates 
the culture chamber into two levels.  During the device operation, the cells will be loaded 
via the PDMS channels, and the membrane allows cells to be efficiently collected, 
eliminating the need to coat the microfluidic channels with cell attachment factors.  
During the cell assay experiments, cells will be maintained at the cell culture level, on top 
of the membrane and treatment solution will be delivered via the fluid delivery level, at 
the bottom of the membrane.  To expose all chambers to a common fluid solution such as 
during washing or staining the cells, fluid can be injected via the cell loading inlet or the 
outlet ports.  For treating cells under combinatorial conditions, the fluids will be injected 
into combinatorial mixer inlets.  The chamber for cell culture on the PDMS chip is 100 
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µm height and 600 µm in diameter and the chamber on the Parylene chip is 90 µm height 
and 1,000 µm in diameter.  This results in a total volume of 100 nL.  As typical cell 
culture has cell density range from 104 to 107 cells/mL, this would translate to about 1 to 
1,000 cells per chamber.  Typical cell culture procedure calls for changing of media every 
two to three days, so cells within the chambers under that density range should have 
sufficient nutrients to grow in two to three days without culture media change. 
 
Figure 4-4. Layout of the PDMS microfluidic chip. 
 
4.2.2 Device Fabrication  
 
The fabrication process for constructing 3-D microfluidic Parylene chip is based 
on the developed fabrication method for monolithically constructing 3-D microfluidic 
networks as described in the previous chapter.  The process flow for the surface 
micromachining process is shown in Figure 4-5.  Soda lime glass wafer (thickness of 500 
µm) was cleaned with Piranha solution (H2SO4: H2O2, H2O; 5:1:1) at 120oC for 5 minutes.  
The wafer was then soaked in 0.5% silane A-174 (Specialty Coating Systems, 
Indianapolis, IN) solution (DI water: IPA: A-174, 100:100:1) for 15 minutes to promote 
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the adhesion between the substrate and Parylene C.  A first thin adhesion layer of 
Parylene C was deposited (3 µm) on the wafer. The first sacrificial photoresist layer 
(AZ4620 from Clariant, Charlotte, NC) was spin-coated (14 µm) and patterned to define 
the first-level channels.  A second layer of Parylene C (10 µm) was then deposited to 
cover the sacrificial photoresist, forming the first-level channels.  Parylene C was 
patterned using oxygen plasma so the areas where the overpass structures would be 
joined were exposed.  This Parylene patterning also opened the area where the mixer and 
the culture chamber would be connected.  A second sacrificial photoresist was spin-
coated (25 µm) and patterned to define the overpass structures and the culture chambers.  
This second sacrificial photoresist covered the areas that were etched open, and the 
overpasses spanned several of the first-level microfluidic channels.  A third layer of 
Parylene C (2 µm) was deposited.  The whole chip was planarized with thick SU8 (90 
µm) and Parylene C was patterned to define the access holes.  To improve SU8 strength 
and adhesion to the bottom layers, after SU8 developing, the SU8 was subject to flood 
exposure under an UV canon for 3 minutes to further crosslink all SU8 molecules before 
hard baking the SU8 at 100oC for 90 minutes.  As a result, acetone was able to be used to 
dissolve the sacrificial photoresist.  Acetone can dissolve photoresist quicker than 
isopropyl alcohol, which was used in the previous processes.  However, acetone can also 
cause delamination and device failure while isopropyl alcohol causes such process at 
slower rate.  Using the extra step to further harden the SU8, we were able to dissolve the 
sacrificial photoresist in heated (35oC) acetone without device failure and the chip release 
process can be done in three days instead of one week.   After sacrificial photoresist 
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dissolution, the remaining hollow Parylene structures become the fluidic networks of the 
chip. 
 
Figure 4-5. The monolithic fabrication process for making the 3-D microfluidic Parylene-
based chip. 
 
 The PDMS microfluidic chip (4 mm thickness) was fabricated using the micro-
molding process as shown in Figure 4-6.  A 100 µm SU-8 was spin-coated on silicon 
wafer and patterned by photolithography.  Then, the SU-8 mold was coated with 2 µm 
Parylene C to prevent PDMS from sticking to the mold.  Polydimethylsiloxane (PDMS) 
(Sylgard 184, Dow Corning, Midland, MI) was prepared with a 10:1 ratio of silicone base 
and curing agent and poured onto the mold.  The PDMS was cured in oven at 80oC for 30 
minutes.   The PDMS was peeled off and trimmed to size of 2.5 cm × 2.5 cm and the 
fluidic ports were punched with a 23 gauge flat tip needle.   
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Figure 4-6.  The process for making the PDMS chip.   
  
 Track-etched porous PET (polyethylene terephthalate) membranes with size of 
0.5 cm × 1.5 cm were cut off from cell culture inserts.  Membranes with 0.4 µm pore 
diameter have pore density of 4 × 106 pores cm−2 and were cut off from Corning 
Transwell 24 mm diameter inserts (Corning, Corning, NY).  Membranes with 1 µm pore 
diameter have pore density of 1.6 × 106 pores cm−2 and were cut off from BD Falcon 24 
mm diameter inserts (BD Biosciences, Bedford, MA). 
4.2.3 Device Packaging and Operation  
 
For device packaging, the porous membrane was placed onto the chamber area of 
the PDMS chip and the PDMS chip with the membrane was aligned onto the 3-D 
microfluidic Parylene chip.  The PDMS and the Parylene chip were clamped together by 
two pieces of transparent acrylic that were milled with a computer-numerical-controlled 
(CNC) machine.  With the membrane, the culture chamber turns into a two-level 
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configuration (Figure 4-1(b)).  The PDMS also provided proper sealing and acted as an 
adapter to connect the tubes.  Metal hollow tubes (0.025 inch OD × 0.013 inch ID × 0.25 
inch length) were inserted into one end of Teflon tubes.  The Teflon tubes were 
connected with syringes and plugged into the ports of the piece of PDMS.  This 
packaging method allows other PDMS microfluidic chips to be integrated and provides 
the opportunity to construct more complicated device by adding components such as 
check valves, active valves and pumps.   
4.2.4 Microfluidic Simulation 
 
 The mass and momentum transfer at the two-level culture chamber area was 
modeled in 2-D using finite element analysis with Comsol Multiphysics (Comsol, 
Burlington, MA).  The configuration in Figure 4-7 was used.  For the velocity profile 
simulation, the steady state incompressible Navier-Stokes application mode was 
implemented.  The density and viscosity of water, 1 g cm−3 and 10−3 Pa·s, respectively, 
were used.  The fluid flows into the inlet at a flow rate of 10−2 m s−1 and flows out via the 
outlet.  In addition, simulation was done to ensure that molecules entering the inlet can 
reach the cell culture level in a sufficiently short amount of time.  The multiphysics 
application mode with the combined incompressible Navier-Stokes model and transient 
diffusion/convection model was used.  Both types of membranes that were used in this 
work were simulated; the membrane with 0.4 µm pore size has a pore density of 4 × 106 
pores cm−2 and the membrane with 1 µm pore diameter has a pore density of 1.6 × 106 
pores cm−2.  The diffusion constant of a small protein in water, D = 10−6 cm2 s−1 was used.   
Initially, the unsteady state flow profile was solved from 0 to 780 seconds with a time 
step of 30 seconds, and the solution at each time step was saved.  Then, the 
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diffusion/convection module was applied and the concentration profile at each time step 
was solved using the saved fluid velocity profile.  The two models were not solved 
together to save computation power.   
 
Figure 4-7.  The configuration used for fluid simulation at the two-level culture chamber 
area.   
 
4.2.5 Combinatorial Mixer Characterization 
 
To characterize the concentration of the three input compounds inside each 
chamber, we packaged the device with a piece of PDMS with only the combinatorial 
mixer inlet and outlet ports.  A red fluorescent molecule, sulforhodamine 101 (Sigma-
Aldrich, St. Louis, MO), was used.  We first tested if the fluorescence intensity would 
vary linearly with concentration.  Background intensity was first measured by injecting 
DI water into the chamber.  The fluorescence image of the chamber was captured with a 
Nikon E800 upright fluorescence microscope with a G-2E/C filter (Nikon Instruments, 
Melville, NY) and fluorescence intensity was measured using ImageJ.  Stock solution of 
sulforhodamine 101 was prepared at 3.3 mM by dissolving it in dimethyl sulfoxide 
(DMSO), and working solution was obtained by diluting in DI water.  Then, 
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sulforhodamine 101 solutions at different concentrations, 2.0625, 4.125, 6.1875, and 8.25 
µM, were injected into the chamber.  The fluorescence image of the chamber was 
captured and fluorescence intensity was measured using ImageJ.  Background intensity 
was subtracted from the measured fluorescence intensity.   
To characterize the combinatorial mixer, we first injected a red fluorescence 
solution, 8.25 µM sulforhodamine 101, into input A, while injecting DI water into input 
B, input C, and control.  The injection was controlled by syringe pumps and was set at 5 
µL min−1 for duration of 20 minutes.  After ten minutes, the fluorescence image of each 
chamber was captured with an upright fluorescence microscope with a G-2E/C filter.  
The fluorescence intensity was measured using ImageJ and background intensity was 
subtracted.   The fluorescent concentration at each chamber was normalized against the 
input concentration.  Fluorescence solution was then switched to input B, while injecting 
DI water into other inlets. The same procedure was repeated for input C.  The device was 
flipped over during imaging so the backside (the glass wafer side) was facing the 
objective.  The backside acrylic had a milled slot so the excitation light and emission 
light can directly reach the glass side without interference from the acrylic.   
4.2.6 Device Operation for Cell-Based Assay On-Chip  
 
The device operation of a typical cell assay experiment is shown in Figure 4-8.   
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Figure 4-8. Typical device operation for cell-based assay using this device. (a) 
Suspension of cells was injected into the chip via the cell loading port, and cells were 
efficiently collected by and grown on the membrane. (b) Following incubation at static 
condition for cell attachment, the compounds for treatment can be injected via the 
combinatorial mixer inlets, while keeping the cell loading port sealed with a solid 
stainless steel pin.  (c) Reagents for washing the cells can be injected either via the outlet 
or the cell loading inlet.  (d) Live/dead cell stains can be injected at the end to assess the 
viability.   
 
Before the device assembly, the PDMS chips and 3-D Parylene chips were 
sterilized with UV and ultrasonicated in ethanol for 10 minutes followed by 
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ultrasonication in water for 5 minutes.  After the devices were assembled, the devices 
were rinsed with DI water and filled with media prior to use.  The porous membranes 
were sterilized by the manufactures, and a new piece of membrane was used for every 
experiment.  The microfluidic channels were primed with water followed by cell culture 
media.  Suspension of cells was loaded into syringe and was injected into the chip via the 
cell loading port.   Cells were efficiently collected by and grown on the membrane, which 
was cell culture treated by the manufactures.  Following incubation at static condition for 
cell attachment, the compounds for treatment can be injected via the combinatorial mixer 
inlets, while keeping the cell loading port sealed with a solid stainless steel pin.  Reagents 
for washing the cells and staining cells can be injected either via the outlet or the cell 
loading inlet to replace the treatment compound solutions.  After certain period of 
incubation, live/dead cell stains can be injected to assess the viability of the cells on-chip. 
 Two cell-based assays were performed using this device and the general device 
operation follows the procedure described previously.  The details of both experiments 
are described in the following sections.   
4.2.7 Assay for Compounds’ Ability to Reduce Cytotoxicity of Hydrogen Peroxide 
 
 This microfluidic device was used to assay for the ability of 1,5-
dihydroxyisoquinoline (ISO), deferoxamine (DFO), and 3-aminobenzoic acid (ABA) to 
alleviate cytotoxicity of hydrogen peroxide, which is generated during brain ischemia and 
reperfusion injury and various neuropathological conditions [87].  B35 rat neuroblastoma 
cells were cultured in 100 mm × 15 mm polystyrene petri dishes and passaged every two 
to three days.  All culture reagents were purchased from Invitrogen (Carlsbad, CA) unless 
otherwise stated.  The cells were maintained in Dulbecco’s Modified Eagle’s Medium 
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(DMEM) with 10% fetal bovine serum and 1% penicillin/streptomycin/amphotericin B, 
and incubated in 5% CO2 at 37oC.  The three compounds, 1,5-dihydroxyisoquinoline 
(ISO), deferoxamine (DFO), and 3-aminobenzoic acid (ABA) were all purchased from 
Sigma-Aldrich (St. Louis, MO).  Stock solution of 1,5-dihydroxyisoquinoline was 
prepared by dissolving it in dimethyl sulfoxide (DMSO) at a final concentration of 60 
mM.  Stock solution of deferoxamine was prepared by dissolving it in Dulbecco's 
phosphate buffered saline (DPBS) at a final concentration of 76 mM.  Stock solution of 
3-aminobenzoic acid was prepared by dissolving it in dimethyl sulfoxide (DMSO) at a 
final concentration of 800 mM.  The device was packaged with the porous membrane 
with 0.4 µm pore diameter.  Cells were suspended using 0.25% trypsin (0.25% (w/v) 
trypsin, 0.53 mM EDTA solution) and suspension of B35 cells was injected into the cell 
loading port.  The cells were collected by and grown on the membrane.  Following three 
hours of incubation inside the incubator after cell seeding, each compound (300 µM ISO, 
1 mM DFO, 1 mM ABA) was mixed in DMEM media containing 1.5 mM hydrogen 
peroxide and injected into the combinatorial mixer inlets at 5 µL min−1 for 30 minutes, 
followed by static condition inside the incubator for five minutes, while keeping the cell 
loading inlet sealed with a solid stainless steel pin.  Then, fresh DMEM solution was 
injected into the cell loading inlet to replace the treatment solutions, and the cells were 
rinsed again by injecting DMEM via the outlet, while keeping the cell loading inlet 
sealed.  The cells were incubated under static condition inside the incubator for three 
hours.  Live/dead cell stains (2 µM calcein AM/2 µM propidium iodide) were injected 
via the cell loading inlet and the cells were incubated for 10 minutes.  Calcein AM can 
permeate the cell membrane and the lipophilic blocking groups are cleaved 
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nonspecifically by intracellular esterases.  The hydrolyzed form, calcein, results in a 
charged green fluorescent compound that is retained very well inside the cells.  Therefore, 
green fluorescence is an indicator of live cells.  Propidium iodide is a red fluorescent 
molecule that can only pass through cells with compromised membranes and bind to the 
nucleic acids.  Thus, propidium iodide indicates dead cells.  Often, there would be cells 
that are stained by both dyes and they are counted as dead cells because their membranes 
are already compromised while some intracellular esterases are still present.  The 
visualization and fluorescence image capturing of the cells were carried out using a 
fluorescence microscope with a G-2E/C and B-2E/C filters, and cytotoxicity was 
determined by the ratio of dead cells to total cells.  Four experiments were done for this 
assay. 
4.2.8 Assay for Exposing Breast Cancer Cells to Chemotherapeutic Agents 
 
 The device was used to assay for the cytotoxic activity of three chemotherapeutic 
agents, vinorelbine (VIN), paclitaxel (PAC), and γ-linolenic acid (GLA), on human 
breast cancer carcinoma, MDA-MB-231 cells (American Type Culture Collection, 
Manassas, VA).  The cells were maintained in Dulbecco’s Modified Eagle’s Medium 
with 10% fetal bovine serum and 1% penicillin/streptomycin/amphotericin B, and 
incubated in 5% CO2 at 37oC.  The three compounds, vinorelbine (VIN), paclitaxel 
(PAC), and γ-linolenic acid (GLA), were all purchased from Sigma-Aldrich (St. Louis, 
MO).  Stock solution of vinorelbine was prepared by dissolving it in Dulbecco's 
phosphate buffered saline (DPBS) at a final concentration of 10 mM and stored at 4oC.  
Stock solution of paclitaxel was prepared by dissolving paclitaxel in dimethyl sulfoxide 
(DMSO) at a final concentration of 10 mM and stored at 4oC.  Stock solution of γ-
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linolenic acid was prepared by dissolving γ-linolenic acid in ethanol at a final 
concentration of 120 mM and stored in the dark at −20oC.  The device was packaged with 
the membrane with 1 µm pores.  Suspension of cells was injected into the cell loading 
port and trapped and cultured on the membrane surface.  Following three hours of 
incubation after cell seeding, each compound (8 µM VIN, 2 µM PAC, 50 µM GLA) was 
mixed in complete culture media and injected into the combinatorial mixer inlet at 10 µL 
min−1 for 5 minutes, while keeping the cell loading inlet sealed with a solid stainless steel 
pin.  Then, the cells were incubated with the treatment solutions for another 25 minutes 
inside the incubator.  Afterwards, normal culture media was injected through the cell 
loading port to replace the treatment solutions, and the rinsing was done again by 
injection through the outlet, while keeping the cell loading inlet sealed.  The cells were 
then incubated for another 24 hours.  Live/dead stains (2 µM calcein AM/2 µM 
propidium iodide) were injected and incubated for ten minutes, and the cells were 
visualized with a fluorescence microscope.   The cytotoxicity was determined by the ratio 
of dead cells to total cells.  Six experiments were done for this assay.   
 
4.3 Results and Discussion 
4.3.1 Combinatorial Mixer Characterization 
 A fabricated Parylene chip and a packaged device with three different colors of 
food coloring solutions injected are shown in Figure 4-9.  The chip was able to withstand 
releasing in warm (35oC) acetone without any delamination of the SU8 or Parylene layers.  
In contrast to the previous chip built on silicon, this version is based on glass substrate 
and is more compatible with microscopy.  Both SU8 and Parylene C are transparent and 
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will allow the experiments to be observed from either side of the chip.  The tubes will no 
longer obstruct the microscope objectives as the objectives can be used on the different 
side from the tubes.  Fluid delivery follows the same straightforward procedure as 
previously described, using syringes and syringe pumps.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-9. (a) Fabricated Parylene chip after sacrificial photoresist dissolution.  (b) 
Experiment setup to deliver food coloring solutions into the chip.  (c) Packaged device 
with various food coloring solutions injected. 
  
Figure 4-10 shows the serial dilution experiment with sulforhodamine 101 by 
measuring the fluorescence intensity of sulforhodamine 101 at various concentrations on-
chip.  The linear fit of that data is included and has a coefficient of determination, r2, 
value of 0.9995.  The result shows that sulforhodamine 101 has fluorescence intensity 
(a) 
(b) (c) 
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that varies linearly with the concentration at the concentration range we will work in and 
is suitable for our experiment. 
 
Figure 4-10. Serial dilution of sulforhodamine 101 on-chip. 
 
Figure 4-11 shows the concentration of the three input compounds at each 
chamber.  The combinatorial mixer was able to generate the correct combinations of the 
compound solutions.  The experiment was done by injecting red fluorescent 
sulforhodamine 101 solution into one of the combinatorial inlet while injecting DI water 
into the other inlets.  Fluorescence image of each chamber was taken and the 
fluorescence level was measured with ImageJ.  The same procedure was repeated for the 
other two combinatorial mixer inlets.  While it is possible to use three fluorescent 
compounds with different excitation/emission spectra and injecting one compound into 
one separate inlet simultaneously, we avoided such procedure to prevent possible 
fluorescence crossover among the three fluorescent molecules.  The concentration of the 
compounds can deviate from the design value because of dimensional inaccuracy in 
processing.  Also, the sacrificial photoresist was baked during fabrication and this 
resulted in the edge of channel to be rounded and deviated from the rectangular profile 
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that was used when calculating fluidic resistance.  A more precise control during the 
fabrication process can result in the concentration profile better matching the design 
values.  This characterization allows us to know the concentrations of the input 
compounds at each chamber.  Such information will assist us in deciding the input 
treatment compound concentration and let us know the treatment compound 
concentration at each chamber for the cell assay experiments.  This method can be 
adopted for characterizing combinatorial mixer with higher inputs as choosing four or 
more fluorescent molecules with non-overlapping emission/excitation spectra can be 
difficult and add to the cost because four or more optical filters for the fluorophores have 
to be obtained.   
 
 
Figure 4-11. Fluorescence characterization of the combinatorial mixer showing the 
concentration of the three input compounds at each chamber.  Error bars are one standard 
deviation (SD).  Number of experiments = 3.   
 
The combinatorial mixing can be treated as matrix operation, shown as a linear 
equation, Ex = O.  E represents the components of each input, x represents the 
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combinatorial function of the chip and O is the output components.  For the current 
device with three-input combinatorial mixer (with one unmixed control), the matrix 
operation is 
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For the input matrix E, the components, A, B, and C represent the individual inputs and 
the component in each column represents the concentration of the individual input 
compounds in input A, input B, and input C.  For example, if we inject solution I1 into 
input A, I2 into input B and I3 into input C, the input matrix E would be  
E = 








3
2
1
00
00
00
I
I
I
.                                                         (4.8) 
 
The combinatorial mixer operator, x, governs how the inputs will be combined into the 
outputs. With the original combinatorial mixer design, the matrix operation is represented 
as 








3
2
1
00
00
00
I
I
I












01
2
1
2
1
3
1
00
2
10
3
1
000
2
1
3
1
000
1
2
10
0
2
11
 = 










01
2
1
2
1
3
1
00
2
10
3
1
000
2
1
3
1
000
1
2
10
0
2
11
3333
22
11
22
11
IIII
II
II
II
II
. (4.9) 
 
Each column in the output matrix, O, represents the compounds and concentrations in 
each chamber.  Characterizing the combinatorial mixer allows us to know the values for 
the combinatorial mixer operation of the device and the equation becomes 
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







3
2
1
00
00
00
I
I
I








0164.049.025.0
0032.0026.0
00054.05.0
000
15.00
055.01
  = 








0164.049.025.0
0032.0026.0
00054.05.0
000
15.00
055.01
3333
22
11
22
11
IIII
II
II
II
II
. (4.10) 
 
Knowing the values in the combinatorial mixer operator allows other output 
combinations to be designed using the same chip.  As the values in the matrix x have 
been determined, one can choose the desired output and solved for E in the matrix 
operation, Ex = O. 
For example, if the output 








01832.0652.0556.0
0016.0324.043.0
00096.0216.0278.0
6.0465.03.0
5.058.06.0
3.037.04.0
3333
222
111
333
222
111
IIII
III
III
III
III
III
 is 
desired, one can solve for the necessary input matrix to generate such output.  The input 
would be








333
22
11
6.03.0
05.06.0
03.04.0
III
II
II
, and the whole matrix operation is  


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

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






0164.049.025.0
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= 








01832.0652.0556.0
0016.0324.043.0
00096.0216.0278.0
6.0465.03.0
5.058.06.0
3.037.04.0
3333
222
111
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222
111
IIII
III
III
III
III
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.  (4.11) 
 
It is noted that not all possible output can be generated because certain output 
combination would require inputs to have negative concentration.  By characterizing the 
combinatorial mixer and transforming the combinatorial mixing into a matrix operation, 
we can expand the possible combinations of experiments that can be done using the 
current chip and also lay the foundation for easily designing and characterizing future 
devices with more inputs and outputs.   
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4.3.2 Device Packaging with Integrated Membrane and Microfluidic Simulation 
For the cell assay experiments, porous PET (polyethylene terephthalate) 
membranes were incorporated into the device packaging and the culture chamber area 
was turned into a two-level configuration.  Figure 4-12 shows a cell culture experiment 
on this chip.  The B35 rat neuroblastoma cells were loaded and captured by the 
membrane and grown at a continuous perfusion of culture media that was injected 
through the outlet at 80 nL min−1, while keeping the cell loading inlet sealed with a 
stainless steel pin.  The cells eventually reached confluency after 70 hours.   
 
Figure 4-12. Cell culture inside the culture chamber with integrated membrane.  (Left) 
Cells loaded into the chamber.  (Right) Cell population reached confluency after 70 hours.   
 
The integrated membrane served several purposes and greatly facilitated the on-
chip cell assay experiment.   Cell seeding in many other microfluidic cell culture devices 
was done by flowing cell suspension through channels that were coated with attachment 
factors such as collagen or fibronectin.  Many cells can be lost in this process and the 
pretreating of the channel surface with attachment factor can take 4 hours to 24 hours.  In 
our previous chip, the channel walls were pretreated with 0.05% polyethyleneimine (PEI) 
solution for 24 hours for cell to adhere during cell loading and proper cell spreading after 
incubation.  With the porous membrane, cells were injected into the cell loading port of 
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the PDMS chip and cells were efficiently trapped on the porous membrane at the culture 
chamber area.  The membrane also provided a proper surface for cell growth because the 
membrane was cell culture treated by the manufactures with oxygen or nitrogen plasma.  
The need to pretreat the channel surfaces was eliminated.  The membrane is inexpensive 
and disposable so a new sterile membrane can be used for each experiment.  In addition, 
studies have shown that growing cells on porous membrane allows cells to access media 
from both apical and basolateral sides and results in an in vivo-like environment and 
improved cell morphology [88].  Our packaging method to allow membrane to be 
incorporated into microfluidic devices is straightforward and the method allows PDMS 
microfluidic chip to be integrated.  Integrating various components can extend the 
versatility of the devices.  Different types of membrane can be used depending on the 
applications, and other PDMS microfluidic chips such as concentration diluter can be 
integrated.  This method of incorporating membrane into microfluidic devices can be 
extended to other devices as the use of membrane in microfluidics has increased in recent 
years for process such as concentration, filtration or other cell studies.   
In addition, the two-level configuration allows the cells to be kept in the cell 
culture level and be separated from the fluid delivery level during cell assay experiments.  
This setup minimizes the exposure of cells to direct fluid flow and the resultant shear 
stresses, which can cause adverse effect to cells.  Finite element analysis of the fluid 
velocity modeling was done using Comsol Multiphysics, and Figure 4-13 shows the 
simulated fluid velocity profile.   
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Figure 4-13. Fluid velocity profile at the two-level culture chamber for (a) 0.4 µm porous 
membrane and (b) 1 µm porous membrane.   
 
For both membrane pore sizes, the majority of the fluid flow occurs inside the 
fluid delivery level and the fluid flow inside the culture level is minimal.  Also, the fluid 
velocity inside culture level is very uniform, resulting in a uniform growth environment 
for the cells.  For microfluidic perfusion system, the 2-D Poiseuille flow results in an 
estimated shear stress at the wall,  
wh
Q
2
6  ,                                                              (4.12) 
 
where τ is the shear stress, µ is the viscosity, Q is the flow rate, h is the channel height 
and w is the channel width.  As the flow rate inside the culture chamber level is reduced, 
the shear stress at the wall is reduced as well. 
Finite element analysis using the combined Navier-Stokes and 
diffusion/convection model was done to simulate the solute transport during cell assay 
and results show that the transport of treatment molecules from the fluid delivery level 
(b) 
(a) 
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into the cell culture level is dominated by diffusion.  The membrane is thin (10 µm) with 
high porosity (4 × 106 pores cm−2  and 1.6 × 106 pores cm−2 for the 0.4 µm and 1 µm pore 
size membranes, respectively) and this allows the treatment compounds to quickly reach 
the cell culture area.  Figure 4-14 shows that for the membrane with 0.4 m pore diameter, 
molecules (D = 10−6 cm2 s−1) can reach the cell culture surface in a short time, 270 
seconds, and fill the entire chamber within 660 seconds.  The membrane with 1 µm pore 
diameter allows even faster transport of molecules, filling the entire chamber in less than 
450 seconds.  It is noted that cells are residing on top of the membrane and as soon as the 
molecules cross the 10 µm membrane, the molecules can start affecting the cells and it is 
not required for the molecules to fill the entire chamber for them to take effect.  The 
simulation results show that our device setup is appropriate for exposing cells to different 
compounds and those compounds can be delivered to the cells efficiently without 
disturbance from convection. 
 
Figure 4-14. Simulation of the solute transport at the two-level culture chamber area.  
Concentration profile was shown for 0.4 µm pore membrane (a–d) and 1 µm pore 
membrane (e–h).   D = 10−6 cm2 s−1. 
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 In addition, this configuration mimics the in vivo interstitial environment as fast 
convective flow dominates the fluid delivery level that resembles blood flow in tissue and 
diffusion dominates the cell culture level with low shear stress.  The Peclet number 
extracted from the simulation model at the height of cell (10 µm) is around 0.1, which is 
similar to the value inside the tissue.  The effect of such culturing environment on the 
cells will be investigated in future works.  Such ability to create a physiologically 
relevant condition is one unique advantage for microfluidic devices and is unavailable for 
conventional culturing containers such as flasks or well plates.  Further additions can be 
made such as culturing cells in gel or co-culturing with other cell types to further 
simulate the various characteristics of the in vivo cellular microenvironment.  As cell-
based assays use cells as model for studies such as drug response, it is important that cells 
be kept in an environment as close to the in vivo environment as possible so the cells 
would behave similarly as they would in human body and test results would be more 
validated.  The integrated membrane serves several beneficial purposes as it simplifies 
the cell loading process and also allows cells to be maintained in an in vivo-like 
environment during the cell assay experiment.   
4.3.3 Oxygen Supply for the Cell Culture Chamber 
 
 The chamber was designed so the cells would have sufficient oxygen during the 
experiment.  PDMS has been known to be a permeable material to gases and would allow 
oxygen to freely pass through.  The oxygen transport through the cell culture chamber 
can be modeled using the configuration shown in Figure 4-15. 
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Figure 4-15. Side view of the culture chamber for oxygen transport modeling. 
 
The cells have an oxygen utilization rate per cell, RO [mol min−1 cell−1], and a 
total consumption rate, OT,  
A
NRO OT  ,                                                  ( 4.13) 
 
where N is the total number of cells per chamber, and A is the surface area of the chamber.  
Flux of oxygen would be constantly transferred from the surface of the chamber into the 
chamber at rate, J, and at steady state, flux of oxygen transferred from surface to the 
chamber equals the consumption rate by the cells. 
A
NRJ O .                                                   (4.14) 
 
J can be expressed by Flick’s first law: 
)()( cw
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ww pp
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  .                     (4.15) 
 
The first part denotes the flux of oxygen through the wall (w), PDMS, with thickness hw 
and the second part denotes the flux of oxygen through the media (m) to the cell surface, 
with thickness hm.  Dw is the diffusion coefficient of oxygen in the wall, αw is the 
solubility of oxygen into the wall, po is the partial pressure of oxygen at the outer surface, 
pw is the partial pressure of oxygen at the inner surface, Dm is the diffusion coefficient of 
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oxygen in the media, αm is the solubility of oxygen into the media, and pc is the partial 
pressure of oxygen at the cell surface. 
The expression can be rewritten and eliminate the term pw, to become  
))/()/((
)(
mmmwww
co
DhDh
pp
J  
 .                          (4.16) 
 
This can be equated to the gas consumption equation and an expression is derived: 
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The maximum cell density, N/A(max), that can be supported by the system can be found by 
plugging in the lowest allowable value of pc, the partial pressure of oxygen at cell surface.  
That value is denoted as pc*, the limiting oxygen concentration below which proliferation 
is not supported, and the value of pc* for hepatocyte, one of most oxygen-demanding 
cells, is 40 mmHg [89].   
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 The oxygen utilization rate, RO, for hepatocyte cell is around 12 fmol min−1 cell−1 
[90].  As PDMS is used as the wall material, the values for Dw and αw are 3.4 × 10−9 
m2 s−1 and 0.34 g m−3 mmHg−1, respectively.  The oxygen inside the media has similar 
property to that of inside the water as the media is a dilute aqueous solution and the 
values for Dm and αm are 2.1 ×10−9 m2 s−1 and 4.32 × 10−2 g m−3 mmHg−1, respectively 
[89].  The partial pressure of oxygen inside the incubator, po, is around 148 mmHg.  As a 
result, the maximum number of cell density, N/A(max) that this chamber can support is 3.7 
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× 103 cells mm−2.  As our chamber has a culture area of 2.8 × 10−1 mm2, this would 
translate to be about 103 cells per chamber.  Typical cell culture experiments have a 
density of 104−107 cells mL−1.  The cell culture chamber has a volume of 100 nL, and this 
would translate to 1 to 1,000 cells per chamber.  Thus, our cell culture chamber, which 
can sustain cell density of 103 cells per chamber with enough oxygen, is sufficient for the 
typical cell density range.  It is noted that the value used for oxygen utilization rate and 
limiting oxygen concentration at cell surface, pc*, is that for hepatocyte, which is more 
oxygen demanding than other cell types.  The cells used in our experiments are 
immortalized mammalian cells and they can use oxygen at rate 10 to 20 times slower.  
For example, CHO, Chinese hamster ovary cell, has a oxygen utilization rate of only 0.5 
fmol min−1 cell−1 [90].  Therefore, the chamber should be able to support more than 103 
cells per chamber for most of the cell types unless oxygen demanding cells such as 
hepatocytes are used.   
4.3.4 Assay for Compounds’ Ability to Reduce Cytotoxicity of Hydrogen Peroxide 
 
 The device was used to assay for the ability of three compounds on reducing the 
cytotoxicity of hydrogen peroxide.  Hydrogen peroxide is generated during brain 
ischemia and reperfusion injury and various neuropathological conditions, and leads to 
significant DNA damage and cell death [87].  B-35 rat neuroblastoma cells were used as 
a model system.  After cell seeding and static incubation for cell adherence, solutions 
containing the individual compounds in DMEM media with hydrogen peroxide were 
delivered into the combinatorial mixer to treat the cells.  After incubation with the 
treatment molecules, the solutions were replaced with normal DMEM media.  Cells were 
incubated and stained with calcein AM (live) and propidium iodide (dead) stains.  Figure 
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4-16(a) shows the result of the cytotoxicity experiment, and Figure 4-16(b) shows the 
arrays of cells after the cells were stained by live/dead stains.    
 
 
Figure 4-16. Result of the assay to test the ability of three compounds, 1,5-
dihydroxyisoquinoline (ISO), deferoxamine (DFO), and 3-aminobenzoic acid (ABA), to 
reduce cytotoxicity of hydrogen peroxide.  (a) Plot of cytotoxicity of the cells, B35 rat 
neuroblastoma cells, at each chamber with different compound exposure. Each compound 
was mixed in media containing 1.5 mM hydrogen peroxide.  Results are the means ± 
standard deviation (SD).  Number of experiments = 4.  (b) Cells in each chamber after 
live (green)/dead (red) staining.   
 
1,5-dihydroxyisoquinoline and deferoxamine showed cytoprotective effect against 
hydrogen peroxide.  1,5-dihydroxyisoquinoline reduces cell death by inhibiting 
Poly(ADP-Ribose) polymerase, whose over-production in response to hydrogen peroxide 
can cause cell death  [91].  Deferoxamine reduces cell death by decreasing the conversion 
of hydrogen peroxide to hydroxyl radicals that damage DNA [92].  3-aminobenzoic acid 
(b) 
(a) 
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is structurally similar to 3-aminobenzamide, which is an agent that can reduce 
cytotoxicity of hydrogen peroxide.  However, it has been shown that 3-aminobenzoic 
acid has no effect on cytotoxicity of hydrogen peroxide.  ISO and DFO were able to 
reduce the cytotoxicity when treating the cells as individual molecules or in combination.  
There did not appear to be synergistic interaction among the two compounds as the 
combination did not increase the ability to reduce cytotoxicity of hydrogen peroxide.  
When either ISO or DFO were combined with ABA, the ability to reduce cytotoxicity 
was not reduced although the concentration of each was lowered.  The efficacy of ISO 
and DFO can start to saturate after reaching certain concentration and this is shown in 
some studies [92].  Separate control experiments were performed with the same cell 
seeding and cell treatment condition, but exposing cells to only DMEM media without 
hydrogen peroxide and the three chemicals.  The cytotoxicity was found to be 4%. 
4.3.5 Assay for Exposing Breast Cancer Cells to Chemotherapeutic Agents 
 
 MDA-MB-231 human breast cancer cells were exposed to combinations of three 
chemotherapeutic agents, vinorelbine (VIN), paclitaxel (PAC), and γ-linolenic acid 
(GLA), using this device.  In this experiment, the device was packaged with a 1 µm 
porous membrane and suspension of cells were loaded and captured by the membrane.  
After incubation for cell attachment, cells were exposed to the various compounds.  
Following incubation with the treatment agents, the cells were washed and culture 
chambers were replenished with normal culture media.  Cells were incubated for another 
24 hours and calcein AM and propidium iodide were loaded to assess the viability of the 
cells.  Figure 4-17(a) shows the result of the cytotoxicity experiment, and Figure 4-17(b) 
shows the arrays of cells after the cells were stained by live/dead stains.  Paclitaxel, a 
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taxane, was first extracted from the bark of western yew trees Taxus brevifolia.  It 
produces its antitumor activity by binding to microtubules of the cells, causing 
polymerization and stabilization.  The inability for depolymerization of microtubules 
disables the cells from completing cell division [93].  Vinorelbine, a semisynthetic vinca 
alkaloid, also binds to microtubules, but disrupts microtubule functions by inducing 
depolymerization and loss of mitotic spindle [94].  Both drugs have been used in cancer 
chemotherapy with demonstrated clinical activity against breast cancer.  γ-linolenic acid 
has been shown to suppress tumor growth and metastasis and is a potential anticancer 
drug.  More importantly, researches have shown that γ-linolenic acid can potentiate the 
cytotoxicity of several anticancer drugs such as vinorelbine, paclitaxel and doxorubicin 
[95, 96].  Studies have also shown that paclitaxel and vinorelbine to have synergy when 
used in combination [97].  As seen in Figure 4-17(a), all three compounds showed 
antitumor activity when treating the cells as a single agent.  When cell were exposed to 
the combination of γ-linolenic acid and vinorelbine or paclitaxel, the cytotoxicity 
increased even with reduced concentration of the compounds.  In the control chamber, 
the cells were not exposed to any of the three agents and the cytotoxicity was around 4%. 
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Figure 4-17. Result of the assay for exposing breast cancer cells, MDA-MB-231, to 
chemotherapeutic agents, vinorelbine (VIN), paclitaxel (PAC), and γ-linolenic acid 
(GLA).  (a) Plot of cytotoxicity of the cells.  Results are the means ± standard deviation 
(SD).  Number of experiments = 6.  (b) Cells in each chamber after live (green)/dead (red) 
staining. 
 
This device successfully demonstrated that with just three inputs, eight distinct 
cell-based assay experiments were performed with different combinatorial compounds 
using a single chip.  The cell seeding was simple and efficient as the one-to-eight splitter 
loaded cells to all chambers at once and the porous membrane trapped the cells at the 
chambers.  Using the integrated combinatorial mixer saved numerous pipetting steps that 
have to be done to create all the possible combinations.   While only three compounds 
were used on this chip, the chip can be scaled up using the same fabrication steps to 
include four, five or even more inputs by placing the overpass structure to cross over 
(a) 
(b) 
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channels.  This will result in a high-density chip that is able to perform hundreds of 
assays at once and greatly simplify the complexity of the experiments.  In addition, chip-
based assays will provide a cheaper alternative to using robotics and well plates and 
provide finer and more sophisticated fluid control.  This microfluidic device also creates 
culture environment that mimics interstitial environment by creating two flow levels and 
maintaining the cells at the diffusion dominated level with minimized fluid velocity.  
With this device, the experiment did not require many complicated external apparatus 
and setups, and only syringe pumps were used for fluid delivery and fluorescence 
microscope for imaging the cells.   This will allow the whole systems to be simply 
automated with dispensing and imaging systems in the future.  Besides performing 
viability assay, metabolites or gene expression can also be studied on-chip.  Moreover, 
other chip components such as flow cytometer or HPLC, which have been demonstrated 
in our group, can be integrated to create a complete cell-based assay platform for 
quantitative cell biology experiments.     
 
4.4 Conclusion 
 
In this chapter, the development of an integrated 3-D microfluidic device on glass 
for cell-based screening of combinatorial compounds on-chip was discussed.  The 
Parylene-based chip was fabricated using multilayer surface micromachining technology 
and integrated with a PDMS chip and porous PET (polyethylene terephthalate) 
membrane.  The combinatorial mixer correctly delivered the distinct combinations of 
input compounds into the chambers and the concentration of each input compound at the 
chamber was characterized.    The incorporated membrane created a cell culture space 
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with minimized flow velocity and simplified the cell loading and assaying procedure.  
The fabricated chip had three inputs for combinatorial mixer with one control, and output 
eight combinatorial streams to the culture arrays.  We have demonstrated quantitative 
cell-based assay for screening three different compounds’ ability to reduce cytotoxicity of 
hydrogen peroxide and assaying combinatorial exposures of three chemotherapeutic 
agents on breast cancer cells.  Based on the capabilities demonstrated in this chapter, 
devices with high-density cell array and integrated high-input combinatorial mixer can be 
constructed.  Such chip will enable inexpensive high-throughput cell-based assay and 
significantly benefit research in many different fields including drug screening and 
systems biology.  
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Chapter 5: Monolithic Multilevel Microfluidic Networks 
with Integrated Membrane 
 
5.1 Introduction 
 
In the previous chapter, a microfluidic device that incorporated a membrane 
structure was presented.  The membrane facilitated the cell culture and assay process 
while creating a cell culture space that can mimic in vivo conditions.  The straightforward 
method to incorporate the membrane only required clamping a piece of commercially 
available membrane in between a PDMS piece and the Parylene-based chip.  Such 
incorporation method was simple but required a membrane to be placed manually every 
time before experiment.  It is advantageous to devise a process that integrates the 
membrane structure during the 3-D microfluidic fabrication.  As the use of membrane 
with microfluidic device is gaining popularity, such fabrication technique can benefit 
research in that area and improve the ease of use of microfluidic devices.  3-D 
microfluidic devices have already broadened the range of possible applications from 2-D 
microfluidic devices and adding a membrane feature can further add to the versatility of 
the microfluidic devices.  The use of membrane with microfluidic will be introduced and 
several fabrication strategies will be presented.   
The use of membrane as a mean of transport control in microfluidic has grown in 
the past 15 years [98].  One popular use of membrane is in sample preparation.  Song et 
al. used a laser-patterned nanoporous membrane at the junction of a cross channel to 
concentrate the proteins with a concentration factor of 2 to 4 [99].  Samples were moved 
by electrophoretic injection and buffer can pass through membrane while proteins were 
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maintained.  Timmer et al. fabricated a device to increase electrolyte concentration by 
evaporation [100].  A microchannel was covered with Teflon membrane and nitrogen 
was flowed over the channel.  Samples were concentrated as the water vapor can pass 
through the membrane.  Furthermore, membrane has been used for sample filtration on-
chip such as demonstrated by Moorthy et al. to filter blood cells [101].  Researchers have 
integrated membrane on chemical reactor devices on-chip.  Cui et al. fabricated a 
membrane microreactor for the dehydrogenation of cyclohexane to benzene [102].  In 
addition, membranes can function as a surface for gas molecule absorption in gas sensors.  
PDMS has a high permeability for gases and has been used in oxygen sensors as 
demonstrated by Vollmer et al. [103].  Also, PDMS has been used as the material for 
constructing microfluidic cell culture device because oxygen can easily transport across 
the PDMS.  Besides cell culturing, devices have also be made to study oxygen 
consumption by organisms such as E. coli [104].   
Various fabrication technologies have been developed to incorporate membrane 
into microfluidic devices to fulfill different applications.  One of the most straightforward 
methods is by direct incorporation such as our clamping method described in the previous 
chapter.  Besides clamping, membranes can also be incorporated by lamination [105].  
The membrane can be prepared in-house or bought from commercial sources, and can be 
modified by functionalization such as coating with bovine serum albumin [106].  One 
major advantage of using the direct incorporation method is the range of different 
membranes that can be obtained.  Membrane with different materials and morphologies 
can be chosen to suit the need of the particular experiment.  The downsides of such 
method are that 1) care must be taken to ensure that leaking would not occur and 2) such 
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fabrication technique will be challenging to scale up for large-scale production.  
Membranes can be integrated as part of the device fabrication process.   For example, 
free-standing porous silicon as membrane on top of microchannel can be fabricated by 
electrochemically forming the porous silicon and undercutting the silicon substrate to 
release the channel and membrane [107].  Other materials, such as alumina, can be 
formed as free-standing membrane [108].  Silicon wafer was coated with SiN from both 
sides and the backside SiN was etched away, followed by Si etching.  Al was sputtered 
and turned into porous structure by anodization.  While using cleanroom process is more 
expensive and complex than direct incorporation, such technology has other advantages. 
It has precise control over the features to the nanometer range, and more chemical and 
thermal resistant materials are often used for microfabrication.  Furthermore, sealing of 
the device is more reliable using this method.  Another way of integrating membrane is 
by fabricating the membrane in situ after the microfluidic chip is fabricated.  Artificial 
lipid bilayers, which is useful for studying transport of materials across cell walls can be 
prepared at an aperture of a chip by contacting lipid solution with buffers [109].  An UV 
laser beam has been used to induce phase separation of acrylate monomers to form 
membrane in between two pillars [110].  While this method offers the possibility to build 
in membrane on existing chip, the process is very complex and has a very limited range 
of materials to choose from.  Finally, the material used to build channel walls can be used 
as membrane as well.  For example, PDMS channels are permeable to gases.  Hydrogel 
such as calcium alginate has also been used to construct microfluidic channel walls and 
are permeable to solutes such as dextran [111].  This method of integration is simple and 
no extra fabrication steps are required. 
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The fabrication process to construct monolithic 3-D microfluidic networks 
presented in previous chapters can be modified to integrate a membrane structure inside 
the devices.  Here, we expand this technology to create an integrated membrane at the 
interface of the microfluidic channels.  Surface micromachining enables chips to be 
conveniently batch fabricated and the integrated method avoids sealing problems when 
incorporating membrane into devices.  In addition, integration with 3-D microfluidic 
networks expands the complexity of applications for membrane devices.  The channels 
are made up of biocompatible Parylene C and are suitable for biological experiments.  
The device has two-layer microfluidic channels with a porous membrane in between.  In 
this chapter, the fabrication techniques are discussed and the applications of such 
fabrication process are demonstrated. The membrane-based microfluidic device can be 
used for constructing in vivo-like culture chamber and can be used for cell co-culture.   
 
5.2 Experimental 
5.2.1 Design  
 
 Our device is composed of two-level microfluidic networks and a membrane 
structure that is positioned in between the two microfluidic channels (Figure 5-1).  Each 
microfluidic level has its own inlet and outlet ports for sample introduction.  Parylene C 
is chosen as the structural material because of its compatibility with surface 
micromachining processes, which enables 3-D microfluidic networks to be fabricated 
monolithically.  Other advantageous properties of Parylene C include its biocompatibility, 
optical transparency and chemical inertness.  The device is built on a glass substrate for 
ease of observation by microscopy.   
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Figure 5-1. Design layout of the monolithic multilevel microfluidic device with 
integrated membrane.  (a) Top view.  (b) Bi-level chamber with integrated membrane in 
between the two fluidic levels.  (c) Cross section view of the device. 
 
5.2.2 Fabrication 
 
The fabrication process is shown in Figure 5-2.  Soda Lime glass wafer was 
cleaned with Piranha solution (H2SO4: H2O2, H2O, 5:1:1) at 120oC for 5 minutes and 
treated with A-174 silane adhesion promoter for 15 minutes.  Then, the entire wafer was 
coated with Parylene C (2 µm).  A first sacrificial photoresist (15 µm) was spin-coated 
and patterned with photolithography.  A second layer of Parylene (10 µm) was deposited 
to cover the sacrificial photoresist.  Parylene was patterned using oxygen plasma at the 
chamber area to create pores in the membrane.  By modifying the mask of this pattering 
step, membranes with different pore sizes can be created, and membranes with 10, 20, 
and 40 µm pores were made.  A second sacrificial photoresist (30 µm) was defined for 
the second-level channels.  A third layer Parylene was deposited and patterned, followed 
by chip planarization with SU8 (100 µm).  The chips were soaked in isopropyl alcohol 
 
 
 
114 
(IPA) to dissolve the sacrificial photoresist, and the remaining hollow Parylene structures 
became the fluidic networks.   
 
Figure 5-2. Fabrication process flow for the monolithic multilevel microfluidic device 
with integrated membrane. 
 
Similar packaging method as described in the previous chapter was used.  A piece 
of PDMS with punched holes was aligned onto the chip.  The chip and PDMS were 
clamped together by two pieces of transparent acrylic.  Tubes were plugged into the holes 
of the PDMS and on-chip experiments can be observed with a microscope (Figure 5-3).   
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Figure 5-3. Device packaging and testing setup for the monolithic multilevel microfluidic 
device with integrated membrane. 
 
5.3 Results and Discussion 
 
Figure 5-4 shows the fabricated chip after the sacrificial photoresist was dissolved.  
Chips with different sizes of pore diameter (10, 20, and 40 µm) were created.  Pore sizes 
can be conveniently adjusted by changing the design of the photolithography mask and 
smaller size of pores down to 4 µm can be created [112].  Asides from oxygen plasma, 
laser has also been used to etch Parylene to create pores [113].  To create submicron 
pores, techniques such as e-beam photolithography can be used.  Using our fabrication 
technique, membranes were conveniently created in 3-D microfluidic network during 
fabrication.  As a result, sealing of the membrane to prevent leaking would not be a 
concern as in direct incorporation methods.  At the bi-level chamber area, the roof of the 
channel was etched open, but that part can remain if that is desirable for certain 
applications.  Also, more levels of channels can be made by repeating the process of 
patterning sacrificial photoresist, covering with Parylene, etching Parylene to create pores, 
patterning sacrificial photoresist, covering with Parylene, etching Parylene and so on.  
Device packaging followed the straightforward method that was presented in earlier 
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chapters.  Food coloring was injected into the first-level channel and was shown to 
readily enter the second-level channel (Figure 5-4 (c)).   
 
 
 
 
 
 
Figure 5-4. Fabricated monolithic multilevel microfluidic device with integrated 
membrane.  (a) Chip after channel release.  (b) Integrated membrane with 10 µm pores. 
(c) Green solution injected into the first-level channel can enter the second-level channel 
through the membrane.    
 
As discussed in the previous chapter, integrating a membrane in between 
multilevel microfluidic networks can be used to create a culture chamber that mimics the 
in vivo tissue environment, where transport of molecules to the cells is dominated by 
diffusion (Figure 5-5).  The cells can be loaded into the cell culture level, while fluid is 
delivered into the other level.  As the cell culture chamber is separated from the fluid 
delivery channel, shear stress, which can be detrimental to many types of cells, is 
minimized.  A fluid velocity profile simulation was done using COMSOL Multiphysics 
incompressible Navier-Stokes model and the result shows that the flow velocity inside 
the culture chamber is minimal (Figure 5-5).  In addition, with this configuration, culture 
media components delivered into the chamber during perfusion can achieve a uniform 
distribution as the fluid velocity inside the chamber is uniform.  Also, in conventional 
culture containers such as culture flasks, secreted molecules by cells are swept away in 
c 
200 µm 
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random direction by convection as the large air/liquid surface results in significant 
convection.  Such secreted molecules can play an important signaling role in governing 
cellular behaviors such as cancer cell development in vivo [114].  While those molecules 
are randomly distributed in tradition culture vessels, microfluidic device can recreate the 
condition where those molecules remain close by the cells.  Our device presents the 
opportunities for studies to be done to examine how soluble factors from one cell can 
influence the surrounding cells.  The diffusion dominated cell culture space allows 
secreted factors be remained inside the chamber without getting swept away by 
convection. 
 
 
 
 
Figure 5-5. Bi-level cell culture chamber.  (a) Device operation.  (b) Cells inside the 
second-level chamber. (c) Fluid velocity simulation.   
 
Another application for the device is for use in on-chip cell co-culture.  Co-culture 
has been a common method to maintain cell phenotype in vitro, such as co-culture of 
embryonic stem cells with murine embryonic fibroblasts [115], or in studying cell-cell 
interactions [116].  Using a microfluidic device can simplify the process to create the co-
culture configuration, reduce the cells needed for the experiment and recreate a more in 
vivo-like condition.  In our device, different cells can be loaded into different levels of 
chamber, and the membrane allows communication between the two levels (Figure 5-6). 
a 
b 
c 
50 µm 
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40 µm 100 µm 
For the proof-of-concept experiment, rat neuroblastoma cells, B35, were stained with 
green fluorescent calcein AM or orange fluorescent molecule, CellTracker Orange 
CMTMR (5-(and-6)-(((4-chloromethyl)benzoyl)amino)tetramethylrhodamine) from  
Invitrogen (Carlsbad, Ca).  The cells were loaded into the different level of channels.  
More levels of channels can be constructed to simulate complex in vivo microstructures 
such as the three-layer structure (adventitia, media, and intima) of a blood vessel [117].   
 
 
 
 
 
  
 
 
 
 
Figure 5-6.  Device for on-chip cell co-culture. (a) Schematic of device operation for co-
culture.   (b) Different cells were loaded into the different levels of channels.  (c) Cells 
fluorescing orange are underneath the membrane. (d) Cells fluorescing green are on top 
of the membrane. 
 
5.4 Conclusion 
 
 In this chapter, we demonstrated a new method of fabricating monolithic 3-D 
microfluidic devices with an integrated Parylene membrane.  Our fabrication method 
enables devices to be conveniently fabricated at the wafer scale, and our device can be 
integrated with other microfluidic components to build complete lab-on-a-chip systems.  
a 
b c d 
40 µm 
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Using this method, membranes no longer need to be placed into the device assembly 
manually before each experiment, and pore sizes can be varied by changing the mask 
design.  Two possible applications for this device were proposed and preliminary results 
were shown.  This device can have other applications beyond the field of cell biology, 
such as performing experiments in analytical chemistry for sample filtration or 
concentration. 
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Chapter 6:  Applications of Microfluidics in Marine 
Microbiology 
 
6.1 Introduction 
 
The uses of microfluidic devices are not limited to cell culture and cell-based 
assay for mammalian cells as discussed in previous chapters.  Any other types of cells 
can take advantage of the benefits that microfluidic devices offer: high-throughput 
screening, portability, inexpensive platform, and reduced sample volume and reagents.  
Under the collaboration with Dr. David Caron’s group at University of Southern 
California’s Department of Biological Sciences, one area that our group has applied 
microfluidic devices to is in the field of marine biology, specifically in studying algal 
bloom and toxin production by algae.  Algal bloom and toxins produced by different 
algae have always caused problems to the environment and marine ecology.  Due to 
certain favorable changes in environmental conditions, some algae can increase to a large 
density in a short period of time.  For example, many studies have shown a strong 
correlation between phosphorus loading and phytoplankton production in freshwater 
[118].  Some produced toxin and can directly cause sickness or death of organisms such 
as shellfishes that feed on the algae.  The phosphorus can originate from excess nutrients 
in fertilizers that enter the river or sea during water runoff.  More importantly, when large 
quantity of those contaminated shellfishes was consumed by organisms in higher order of 
the food chain, fatalities often resulted.  For example, Alexandrium tamarense, can 
produce saxitoxin and cause paralytic shellfish poisoning [119].  Non-toxic algal bloom 
can lead to harmful effects by disrupting food chains.   
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Pseudo-nitzschia is one type of algae that produces a neural toxin called domoic 
acid, which when transferred through the food chain causes sickness and mortality in 
marine mammals, seabirds and even humans [120].  Perl et al. reported an outbreak of 
domoic acid intoxication in Canada in late 1987 that led to illness of 107 adults and death 
of three elderly people [121].  Mussels were contaminated and resulted in amnesic 
shellfish poisoning with symptoms of gastrointestinal and neurological disorders. Also, 
domoic acid has been linked to the death of numerous sea lions along the California 
coastline in 1998 [122].   
Domoic acid is a neural toxin that affects animals with complex central nervous 
systems.  Domoic acid is structurally analogous to neural transmitter glutamic acid, 
which is present in nearly 40% of all neuronal synaptic sites, and upon binding to 
receptors, domoic acid prolongs receptor activation and excessive cation influx.  This 
uncontrolled influx can cause nerve cells to degenerate.  During Pseudo-nitzschia bloom, 
domoic acid is not always produced.  In another word, growth of algae does not equal 
domoic acid production.  Studies done by other groups have suggested that many factors 
might induce or suppress algae to produce toxin.  Maldonado el al. reported that 
deficiency in iron and copper can induce domoic acid production [123].  Silicate 
depletion has been shown to cause increase in domoic acid production [124].  It has been 
suggested that high phosphate level can lead to increased domoic acid production [125].  
Bacteria strains have also been shown to increase domoic acid production by as much as 
95-fold [126].  Yet, exact causes are unclear and there are numerous possible factors that 
can cause toxin production.  To completely elucidate the causes of toxin production, 
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many potential compounds will have to be screened.  This leads to an enormous number 
of experiments to be performed and large quantity of reagents and cells to be used.   
To facilitate progress in marine biology research and speed up the process of 
screening for possible factors inducing toxin production, we would like to make a chip to 
culture Pseudo-nitzschia under different growing conditions.  The toxin will be detected 
using ELISA method or an ultra sensitive optical sensor being developed at Dr. Chih-
Ming Ho’s lab at University of California at Los Angeles.  The current state-of-the-art 
detection technology indicates that per cell toxin load may range over 2 or 3 orders of 
magnitude but its sensitivity is limited since a sample size of at least 100 cells/mL is 
required.  The new optical sensor will be able to push the sensitivity to 10 cells/mL or to 
even single molecule of domoic acid.   The algal cells will be trapped and cultured on-
chip and combinatorial mixer discussed in chapter 3 and 4 will be used to expose algal 
cells to different conditions.  Cellular contents will be extracted for detection of toxin 
from lysates. 
In this chapter, the development of the applications of microfluidic cell-based 
assaying device for studying toxin production by algae is discussed.  As most algal cells 
are not adherent like the mammalian cells used in previous experiments, on-chip traps 
were needed to contain floating cells like algal cells inside the micro chambers.  Various 
trapping designs will be presented and the developed trapping protocol will be discussed.  
The method to maintain algae in a healthy state and to culture algae on-chip has been 
developed.  As the presence of the intracellular toxin, domoic acid, cannot be directly 
monitored on-chip, a method to lyse the cells on-chip is presented.   
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6.2 Trapping Algal Cells On-Chip 
6.2.1 Trapping Cells with Parylene Posts Inside Micro Culture Chamber 
 
The first-generation cell culture chip with combinatorial mixer on silicon 
substrate described in chapter 3 was equipped with filter structure designed to contain 
floating cells.  The trap is consisted of two rows of rectangular post structures with gap in 
between and the configuration is shown in Figure 6-1.  Each post has a length of 20 µm 
and width of 10 µm.  The gap in between each post is 12 µm and is designed to trap cells 
larger than that dimension.  To fabricate the chamber with traps, photoresist (AZ 4620) 
was first spin-coated on silicon wafer at thickness of 32 µm and soft-baked at 100oC for 
30 minutes.  Then, the post areas were exposed and developed, leaving an array of holes 
on the photoresist.  Those holes were then filled with Parylene C during the subsequent 
Parylene deposition (10 µm).  After the sacrificial photoresist was dissolved with 
isopropyl alcohol, the Parylene posts remained.   
 
Figure 6-1. Configuration of the trap inside the culture chamber of the first-generation 
cell culture chip with combinatorial mixer.   
 
Figure 6-2 shows the SEM image of the cross section of the culture chamber with 
filter.  We were able to integrate filter into the chip without adding extra fabrication steps 
as the sacrificial photoresist patterning and Parylene deposition was already part of the 
fabrication process to construct the culture chambers.   
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Figure 6-2.  SEM image of the Parylene post filter structure.  
 
We tested the filter by first using the algae Prorocentrum gracile as a model.  
Prorocentrum gracile was chosen because it constantly swims around the space it resides 
in and such high mobility is a good indication of healthy cells.  Solution containing the 
cells was injected into the cell loading inlet and image of the chamber was taken with a 
stereoscope equipped with a CCD camera.  Results show that the chamber was able to 
contain algal cells as shown in Figure 6-3.  However, the Prorocentrum gracile cells 
appeared to be stationary and not constantly moving around as in typical healthy cells.  
Some possible reasons might be that the cells dislike the loading conditions such as the 
material of the tubes or culture chamber or the loading pressure.  Another reason might 
be that the culture chamber height of 32 µm was too low and some cells were in contact 
with the walls which impede the cells from moving around.  A cell culture chamber with 
higher ceiling might improve this situation. 
 
Figure 6-3.  Prorocentrum gracile inside the Parylene culture chamber.  Arrow indicates 
one of the cells.   
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6.2.2 Trapping Cells with PDMS Structures 
To investigate whether chamber height can affect compatibility for algal cell 
culture, culture chamber with higher ceiling (100 µm) was fabricated using PDMS.  
PDMS was used because it involved very short fabrication steps so different prototypes 
can be made quickly and various designs can be tested in a short period of time.  The 
PDMS pieces were made following the same protocol as described in chapter 4.  To make 
the post structures, holes were made during patterning of the SU8 for the mold 
fabrication.  When PDMS was casted onto the mold, it filled the holes and became the 
post structures after PDMS was cured.  The cured PDMS was peeled off from the mold 
and cut into pieces.  The PDMS pieces were cleaned with acetone, then isopropyl alcohol, 
followed by water.   The PDMS pieces were reversibly bonded to glass slides by treating 
both glass slides and PDMS pieces with oxygen plasma (50 Watts, 400 mTorr), and 
pressing the PDMS pieces onto the glass slides.  The assembly was baked in oven at 70oC 
for three hours.  Figure 6-4 shows a fabricated device.  The posts consisted of square 
PDMS structure with dimension of 120 µm × 120 µm and the gaps between each post are 
10–20 µm.   
 
Figure 6-4. PDMS chamber with 100 µm height ceiling.  
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 Prorocentrum gracile cells were loaded into the chamber.  As shown in Figure 
6-5, series of pictures were taken at different times and the result showed that the cells 
appeared to be healthy as they moved around constantly.  Chamber height of 100 µm was 
suitable for culturing this type of algae and cells were not stuck by the channel walls and 
had room to float around.   
 
Figure 6-5.  Images of Prorocentrum gracile inside the culture chamber at different times.   
 
Following the creation of the trap that can successfully contain algal cells in a 
healthy state, the next step was to create trap to contain Pseudo-nitzschia.  Unlike 
Prorocentrum gracile and typical mammalian cells, Pseudo-nitzschia has a long, slender, 
rod shape.  The width of the cell is around 2–10 µm while the length is 50–150 µm [127, 
128].  In addition, this type of cell can form into a chain with one cell attaching to the 
other and can reach a total length of 1 mm.  One possible trap configuration that has been 
explored utilizes an array of posts to trap the slender cells and the schematic is shown in 
Figure 6-6.  While the gaps in between the trapping posts are wider than the cell width, 
because the cells are long, they are not able to make the turn to escape the array of posts.   
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Figure 6-6.  Schematic of the trap geometry used to contain Pseudo-nitzschia. 
 
The trap fabrication was based on the same PDMS micro-molding process as 
described previously.  The chamber height was 100 µm.  Each circular post had a 
diameter of 30 µm and a gap between posts of 30 µm.  Four arrays were included with 
each array shifted by 30 µm horizontally and by 30 µm vertically.  Pseudo-nitzschia 
pungens were loaded into syringe and injected into the chamber at high and low 
concentration.  Figure 6-7 shows Pseudo-nitzschia pungens inside the chamber at low 
concentration and Figure 6-8 shows the cells loaded at high concentration.  The trapping 
geometry was able to trap the long and slender Pseudo-nitzschia and the number of cells 
inside the chamber can be adjusted by changing the cell concentration for loading.   
 
Figure 6-7. Pseudo-nitzschia pungens loaded inside the chamber at low concentration.  
Images taken at different magnification.   
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Figure 6-8. Pseudo-nitzschia pungens loaded inside the chamber at high concentration.  
Images taken at different magnification.   
 
6.2.3 Trapping Algal Cells with Membrane-Based Systems 
 
With the successful development of a membrane-based cell culture system as 
described in chapter 4, it became also possible to trap algae using that system.  The 
membrane with pore size of 1 µm was used and the device was packaged with PDMS 
microfluidic chip and Parylene-based chip as described in chapter 4.  Chattonella marina 
and Pseudo-nitzschia pungens were loaded into the chamber.  As seen in Figure 6-9, both 
types of cells were successfully trapped inside the culture chamber. Chattonella marina 
cells were mobile like Prorocentrum gracile and they appeared to be moving around 
constantly inside the chamber, indicating that they were in a healthy state.  The 
membrane-based systems offer a simple and reliable method to maintain algal cells on-
chip and the wide selection of membranes can make trapping cell of any sizes possible.  
After each experiment, the membrane can be disposed and new membrane can be used 
for the new experiment to prevent any contamination from previous experiment and 
possible clogging of the membranes by the cells.   
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Figure 6-9. Pseudo-nitzschia pungens (left) and Chattonella marina (right) loaded into 
membrane-based chamber.  
 
6.3 Culturing of Algae On-Chip 
Experiment was done to test if algal cells can be sustained on-chip.  Membrane-
based device was used with the 1 µm pore size membrane and packaged in the same 
method as described in chapter 4.  The device was then primed with DI water followed 
by culture media, F/2 + Si.  Device operation is shown in Figure 6-10.  Chattonella 
marina and Pseudo-nitzschia pungens were loaded into the culture chamber, and culture 
media, F/2 + Si, was injected via the cell loading inlet at flow rate of 80 nL min−1.  The 
chip was placed inside a refrigerator with temperature set at 15–20oC.  The refrigerator 
was fitted with a fluorescent light bulb (580 lumens, 10 watts, 4100K) and a controller to 
set a 12 hour light and 12 hour dark cycle.    
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Figure 6-10.  Device operation schematic for the culture of algal cells on-chip.   
 
Figure 6-11 shows the image of Pseudo-nitzschia pungens inside the culture 
chamber at different times.  The cells were able to proliferate inside the culture chamber 
under constant perfusion condition as seen in the increase in number of cells.  Figure 6-12 
shows the Chattonella marina inside the culture chamber at different times.  The cells 
proliferated from 0 to 24 hour, but the number remained static afterwards.  The cells were 
still moving around constantly and appeared to be in a healthy state.   
 
Figure 6-11. Pseudo-nitzschia pungens inside the culture chamber at different times.  
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Figure 6-12. Chattonella marina inside the culture chamber at different times. 
 
6.4 Lysis of Algae On-Chip 
 The algal cells loaded on the chip will be cultured and exposed to variation of 
culture media.  Then, their intracellular contents such as toxin would be analyzed.  To 
analyze the intracellular content, the cells will have to be lysed and the lysate will be 
transported out of the chip for analysis.  A straightforward way to lyse the cells on-chip 
using external ultrasonicator is presented in this section.   
 The membrane-based device was used with the 1 µm pore size membrane and the 
fluidic networks were primed with DI water, followed by culture media, F/2 + Si.   
Pseudo-nitzschia pungens were loaded into the chip and the whole packaged device was 
put into an ultrasonicator, PC3 by L&R (Kearny, NJ), with power of 70 watts and 
frequency of 55 kHz.  The water level inside the ultrasonicator bath is approximately 1 
cm, or almost covering the whole thickness of the bottom acrylic piece.  The 
ultrasonicator was turned on and image of the culture chamber was taken at 0, 10, 30 and 
50 seconds.   
 Figure 6-13 shows the result of the ultrasonication.  The algal cells gradually lost 
their color as the cell membranes and cell walls were disrupted by the ultrasonication and 
the chlorophyll came out from the cells.  One can still see some shell-like structures with 
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very faint color at 30 second, but they all eventually disappeared after 50 seconds, 
indicating complete lysis of the cells.  The lysate can then be delivered out of the cells by 
injecting air through the inlet and collecting the liquids at the outlet.   
 
Figure 6-13. Results of the ultrasonication for cell lysis at different times.   
 
6.5 Conclusion 
 
 Applications of microfluidic devices for marine microbiology have been 
demonstrated.  Various schemes for trapping cells have been developed and the method 
to maintain algal cells inside the micro culture chamber in healthy states has been 
presented.  Culture of algal cells has also been performed.  On-chip lysis of the cells has 
been done using an ultrasonicator.  Integration of this device with toxin detector in the 
future will enable high-throughput screening of factors that induce toxin production by 
algae.   
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Chapter 7: Conclusion 
 
 Cell culture and cell-based assay have been key techniques in different fields 
including pharmaceutical industry, cell biology and tissue engineering.  Cell culture was 
a method invented over a century ago and has undergone continuous refinements and 
several breakthroughs.  Various advancements were made to use cells for performing 
assays, and development of sophisticated call-based assays revealed a wealth of 
information from cellular studies.  The complex behavior of cell-cell interactions and 
molecular components of the cells were discovered, making cell-based assay an 
invaluable tool. As the demand for high-throughput screening rises, conventional 
techniques such as well plates and robotics have been continuously engineered and 
improved to meet the demand.  However, these techniques suffered from drawbacks such 
as limited liquid handling ability, inability to scale up well plate density past 1,536 wells 
per plate, and high costs of equipments and operations.   
 Microfluidic emerges as a promising platform to perform cell culture and cell-
based assay in a high-throughput manner.  Microfluidic devices hold several distinct 
advantageous properties including high-throughput, mass fabrication capability, and 
reduction of reagents, cells and cost.  For cell culture use, microfluidic devices have the 
ability to build culturing environment mimicking the microenvironment that cells reside 
in vivo.  Microfluidic, with immense potential, is still a young field with some 
commercialized products.  It was derived from MEMS, which itself was originated from 
silicon semiconductor fabrication technology, but eventually became a major research 
area of its own.  Dramatic increases in publications and new start-up companies showed 
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the burgeoning of the field and growing interest.  The application of microfluidic has 
expanded and demonstrated uses in analytical chemistry, biology, forensics and 
diagnostics.  In this thesis, a novel cell-based assay on-chip is presented. 
 Microfluidic cell culture devices have been created and are still part of ongoing 
researches in different groups in academia.  Many of the other devices being developed 
can only expose cells to a single compound at once.  However, cells are sustained in 
complex environments and received multiple environmental cues simultaneously.  Also, 
combined drugs for treatment of diseases such as cancer and HIV have been promising.  
To screen for the combined effects of multiple compounds at once, an integrated 
combinatorial mixer is necessary.  Such structure would require fabrication of three-
dimensional (3-D) microfluidic networks.  In this work, an integrated method is presented 
to monolithically fabricate 3-D microfluidic networks without performing bonding 
process as in many other methods for 3-D microfluidic fabrication.  The fabrication is 
based on the surface micromachining of biocompatible Parylene C.  Such fabrication 
process presented here can be adopted to create microfluidic chips with complex 
networks and combinatorial mixer with large number of inlets and outlets.  We first 
developed a chip on silicon with a three-input combinatorial mixer plus one unmixed 
control and eight outputs to the cell culture arrays.  Fluidic packaging scheme was 
developed and combinatorial mixing was demonstrated.  Cell culture was successfully 
done using this device and cell treatment with the combinatorial mixer was performed.  
To improve ease of use of the device for cell-based assay, another device based on glass 
substrate was fabricated, and a method to integrate a membrane into the device was used.  
The membrane created a cell culture environment similar to that of in vivo cell culture 
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conditions and also facilitated the cell loading and cell assaying process.  Cell-based 
assays were performed using this device by screening for the ability of compounds to 
reduce cytotoxicity of hydrogen peroxide and combinatorial exposure of 
chemotherapeutic agents.   
 Our 3-D microfluidic fabrication method was extended to make multilayer 
microfluidic networks with an integrated membrane.  Our method offers the ability to 
create a monolithic device, and integrating membrane with 3-D microfluidic also expands 
the functionality of membrane-based microfluidic devices.  Besides mammalian cells, 
microfluidic devices can be used for marine biology.  Algal cell trapping, culturing and 
lysis were demonstrated in microfluidic devices with the eventual goal of making an 
integrated system to screen for the factors that induce toxin production.   
 Our microfluidic devices were designed for cellular studies, but it is possible to 
extend its use to other areas such as combinatorial chemistry or in clinics for testing the 
combination of drugs to treat bacteria infection.  Integrated system with detection and 
fluidic control for sample delivery is also possible.  The development of this platform 
with integration of other components would very likely create devices that can bring 
major impact to drug screening, life science companies and biological researches.   
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